Unspecific neurodegenerative disorder

G6_NEURODEGENERATIVE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — F00, G30 Hospital discharge:* ICD-9 — 3310 Hospital discharge: ICD-8 — 29010 Cause of death: ICD-10 — F00, G30 Cause of death:* ICD-9 — 3310 Cause of death: ICD-8 — 29010 KELA reimbursements: KELA codes — 307 KELA reimbursements: ICD-10 — F00, G30 Medicine purchases:* ATC — N06D 4 out of 7 registries used, show all original rules.	30447
4. Check minimum number of events Min. number of events 3	30447
5. Include endpoints F5_ALZHDEMENT	30447
6. Filter based on genotype QC (FinnGen only)	26818

Control definitions (FinnGen only)

Control exclude: G6_ALZHEIMER

Extra metadata

First used in FinnGen datafreeze: DF12

NAME	G6_NEURODEGENERATIVE
CONTROL_EXCLUDE	G6_ALZHEIMER
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	F5_ALZHDEMENT
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G30\|F00
HD_ICD_9	3310
HD_ICD_8	29010
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G30\|F00
COD_ICD_9	3310
COD_ICD_8	29010
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB	307
KELA_REIMB_ICD	G30\|F00\|3110
KELA_ATC_NEEDOTHER
KELA_ATC	N06D
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Unspecific neurodegenerative disorder based on the number of shared cases.

Similar with more cases:

None

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	26818	12967	13851
Unadjusted period prevalence (%)	5.51	4.60	6.35
Median age at first event (years)	79.59	79.87	79.33

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
22030: Matched controls
150768

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

A04

ICPC

Weakness/tiredness general

2.0

316.6

4334

16243

U04

ICPC

Incontinence urine

2.6

315.8

2194

6146

N03AG01

ATC

valproic acid; systemic, rectal

3.3

314.9

1403

3052

SPAT1234

SPAT

Support of social functional capacity

4.0

307.7

2450

4616

F009, G309,

ICD-10 Finland

2541.2

307.7

372

N06DA02

ATC

donepezil; oral

303.6

307.7

10187

426

OAB76

NOMESCO Finland

General guidance on nutrition and food

28.6

307.7

297

N06AX11

ATC

mirtazapine; oral

1.8

307.7

7533

33624

N06DA03

ATC

rivastigmine; oral, transdermal

250.7

307.7

7075

284

F01.20

ICD-10 Finland

Subcortical vascular dementia without additional symptoms

8.2

307.7

550

472

F00.20*G30.8

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

132.6

307.7

3314

201

A28

ICPC

Limited function/disability NOS

3.1

307.7

8424

24896

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

3.5

307.7

3952

8748

F0019, G301,

ICD-10 Finland

+∞

307.7

621

F00.10

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

634.4

307.7

1308

N05AX08

ATC

risperidone; systemic

10.2

307.7

5648

4931

G31.8

ICD-10 Finland

Other specified degenerative diseases of nervous system

14.8

307.7

430

202

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

1298.6

307.7

4991

TAB00

NOMESCO Finland

Lumbar puncture

4.3

307.7

1203

1986

F00.20

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

372.8

307.7

788

SPAT1254

SPAT

Administration of medicine

2.3

307.7

4809

16070

N06DA04

ATC

galantamine; oral

325.1

307.7

3346

G30.8

ICD-10 Finland

Other Alzheimer disease

355.4

307.7

3236

F06.7

ICD-10 Finland

Mild cognitive disorder

6.4

307.7

2128

2481

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.1

307.7

6878

26909

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

5.6

307.7

752

952

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.0

307.7

9224

39417

R41.0

ICD-10 Finland

Disorientation, unspecified

4.0

307.7

1534

2762

WYA20

NOMESCO Finland

Home visit

7.3

307.7

1080

1059

F02.39*G20

ICD-10 Finland

Dementia in Parkinson's disease without information on additional symptoms

12.6

307.7

500

277

N06AX26

ATC

vortioxetine; oral

3.6

307.7

1475

2932

SPAT1216

SPAT

Assessment of functional ability

2.8

307.7

6194

18759

G20

ICD-10 Finland

Parkinson disease

3.4

307.7

1457

3112

G30.0

ICD-10 Finland

Alzheimer disease with early onset

1246.6

307.7

1173

N05BA04

ATC

oxazepam; oral

2.1

307.7

6625

25483

SPAT1245

SPAT

Provision of support and information to patient’s family members

4.9

307.7

2417

3726

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

878.4

307.7

4971

N06DX01

ATC

memantine; oral

625.3

307.7

12854

337

AXX01, ,

SPAT

4.4

307.7

2247

3832

F05.1

ICD-10 Finland

Delirium superimposed on dementia

18.1

307.7

617

239

SPAT1053

SPAT

Memory test

4.6

307.7

8696

18723

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.4

307.7

5425

17934

SPAT1304

SPAT

Counselling and guidance related to ageing

2.4

307.7

3029

9392

F00.9

ICD-10 Finland

Dementia in Alzheimer disease, unspecified

470.1

307.7

537

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

3.4

307.7

3007

6669

G30.1

ICD-10 Finland

Alzheimer disease with late onset

413.9

307.7

10365

323

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

3.5

307.7

1794

3710

F00.10*G30.1

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

292.8

307.7

4973

150

N05AH04

ATC

quetiapine; oral

4.0

307.7

4942

10120

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.1

307.7

4989

18170

R41.3

ICD-10 Finland

Other amnesia

5.4

307.7

1644

2221

F03

ICD-10 Finland

Unspecified dementia

8.2

307.7

3728

3634

L28

ICPC

Limited function/disability (L)

2.1

307.7

6425

25107

G30

ICD-10 Finland

Alzheimer disease

296.7

307.7

1382

R53

ICD-10 Finland

Malaise and fatigue

2.2

307.7

6950

26082

P70

ICPC

Dementia

34.1

307.7

2698

615

F00.00*G30.0

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

912.0

307.7

772

P20

ICPC

Memory disturbance

11.5

307.7

12235

14791

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

7.4

307.7

6892

8785

AA1AD

NOMESCO Finland

CT of head and brain

2.0

307.7

8866

38263

OAB41

NOMESCO Finland

Guidance and counselling related to ageing

12.3

300.1

374

212

AXX01

NOMESCO Finland

Memory assessment

8.9

297.1

451

353

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

3.3

294.7

1288

2765

N87

ICPC

Parkinsonism

4.8

292.8

784

1161

XA800

NOMESCO Finland

Neuropsychological investigation

3.9

281.9

954

1711

F00

ICD-10 Finland

Dementia in Alzheimer disease

30.7

277.5

244

SPAT1301

SPAT

No procedures

1.7

277.5

7853

36776

I95.1

ICD-10 Finland

Orthostatic hypotension

2.8

275.2

1667

4336

SPAT1101

SPAT

Orthostatic test

2.7

268.5

1680

4445

N05AH03

ATC

olanzapine; systemic

3.2

247.4

1172

2642

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.0

236.7

3403

12843

N02AA05

ATC

oxycodone; systemic

1.7

234.1

5490

24154

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.5

223.0

1695

4929

OAB48

NOMESCO Finland

Lifestyle advice and guidance

13.7

221.5

260

131

N06AB10

ATC

escitalopram; oral

2.0

220.1

3098

11581

A29

ICPC

General symptom/complaint other

1.9

219.0

3605

14206

S01.0

ICD-10 Finland

Open wound of scalp

2.2

218.9

2266

7543

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

2.0

218.0

2816

10206

S72.0

ICD-10 Finland

Fracture of neck of femur

2.5

218.0

1619

4655

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.5

217.2

1630

4710

R1250

NOMESCO Finland

Evaluation of functional capability

3.8

207.8

743

1385

SPAT1252

SPAT

Overall medication plan or its review

2.2

202.9

2093

6947

SPAT1229

SPAT

Assessment of need for aid

2.1

201.7

2398

8413

N02BE01

ATC

paracetamol; systemic, rectal

1.9

201.5

19057

116904

NFB20

NOMESCO Finland

Primary partial prosthetic replacement of hip joint using cement, other or unspecified

2.9

198.6

1084

2651

A06AD11

ATC

lactulose; oral

1.7

191.3

4553

19943

R41

ICD-10 Finland

Other symptoms and signs involving cognitive functions and awareness

6.2

191.1

385

430

N05AD01

ATC

haloperidol; systemic

2.9

191.0

1006

2410

SPAT1246

SPAT

Screening of depression or other psychiatric problem

4.0

190.6

629

1104

F00.00

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

375.8

187.7

218

F05.9

ICD-10 Finland

Delirium, unspecified

3.2

187.3

867

1922

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

185.5

7478

37305

SPAT1360

SPAT

Extensive global examination

2.1

182.0

1925

6442

F00.14

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms of mixed type

478.3

180.4

208

F01.30

ICD-10 Finland

Mixed cortical and subcortical vascular dementia without additional symptoms

8.4

180.3

283

232

R55

ICD-10 Finland

Syncope and collapse

1.8

177.6

3265

13240

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

4.1

175.2

553

937

SPAT1172

SPAT

Guidance concerning hydration

2.9

174.3

930

2243

S06.0

ICD-10 Finland

Concussion

1.9

169.1

2396

8921

AA1AD, ,

SPAT

6.0

168.9

350

403

N27

ICPC

Fear of neurological disease other

3.6

167.8

643

1258

F0009, G300,

ICD-10 Finland

+∞

167.6

187

N04BA03

ATC

levodopa, decarboxylase inhibitor and COMT inhibitor; oral

4.6

163.0

443

663

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

162.7

3828

16625

IHZ08

NOMESCO Finland

Provision of support and information for patient’s relatives

36.0

160.6

136

130

Kela drug reimbursment

Malignant tumour

0.3

159.6

593

11568

F01.9

ICD-10 Finland

Vascular dementia, unspecified

3.2

153.6

696

1521

N05BA06

ATC

lorazepam; systemic, sublingual

2.3

151.3

1390

4379

F0014, G301,

ICD-10 Finland

1186.1

147.5

167

R42

ICD-10 Finland

Dizziness and giddiness

1.5

147.1

5915

29151

Z02.7

ICD-10 Finland

Issue of medical certificate

2.0

143.6

1742

6121

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

143.4

4155

18969

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

139.3

4045

18459

Z75.5

ICD-10 Finland

Holiday relief care

4.6

138.0

376

564

W19

ICD-10 Finland

Unspecified fall

1.8

135.4

2396

9544

SPAT1139

SPAT

Nutrition survey

2.6

134.7

918

2518

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.8

134.5

2555

10396

F00.1

ICD-10 Finland

Dementia in Alzheimer disease with late onset

357.5

134.1

156

F001, G301,

ICD-10 Finland

1059.7

133.1

151

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.9

131.9

1818

6676

N04BD01

ATC

selegiline; oral

3.5

131.2

521

1044

IHZ08, ,

SPAT

7.6

129.8

221

202

AA1CG, ,

SPAT

5.7

127.6

277

335

F0029, G308,

ICD-10 Finland

+∞

127.2

142

F21, ,

ICPC

4.7

126.7

341

506

H02AB02

ATC

dexamethasone; systemic

0.4

124.8

759

11969

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.8

124.1

2309

9324

G31.0

ICD-10 Finland

Circumscribed brain atrophy

6.7

123.9

234

243

F00.19

ICD-10 Finland

Dementia in Alzheimer's disease with late onset without information about additional symptoms

484.9

122.4

141

Z29

ICPC

Social problem NOS

3.3

121.8

511

1062

Z02.4

ICD-10 Finland

Examination for driving licence

0.7

121.4

4839

44674

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.6

121.3

2236

24551

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

118.6

6448

33477

ICB01, ,

SPAT

7.1

118.6

211

204

SPAT1263

SPAT

Sampling

1.4

114.9

8504

46613

W0A10

NOMESCO Finland

Mapping of psychosocial situation

15.2

112.9

126

SPAT1167

SPAT

Insertion of urinary catheter

2.2

110.5

1055

3368

G04BD12

ATC

mirabegron; oral

1.6

110.1

3306

15114

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

109.5

3458

15995

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.7

109.2

2182

8975

AA1BG, ,

SPAT

3.5

108.0

419

826

C10AA01

ATC

simvastatin; oral

1.4

106.4

11378

65975

F01.2

ICD-10 Finland

Subcortical vascular dementia

5.3

106.0

249

326

G04CB01

ATC

finasteride; oral

1.5

105.6

3585

16840

S70.0

ICD-10 Finland

Contusion of hip

2.1

105.4

1081

3551

SPAT1050

SPAT

Extensive neurological examination

2.8

103.8

569

1390

F01.29

ICD-10 Finland

Subcortical vascular dementia without information on additional symptoms

7.3

103.7

181

171

R5110, ,

SPAT

1.7

100.6

2272

9654

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.7

100.1

2365

10170

F02.39

ICD-10 Finland

Dementia in Parkinson's disease without information on additional symptoms

23.9

99.8

N06AB06

ATC

sertraline; oral

1.8

99.8

1603

6170

N04BD02

ATC

rasagiline; oral

4.4

99.1

284

445

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

97.2

6602

35383

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.7

96.9

1867

7588

F00.11

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly paranoidism

756.1

96.5

110

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.8

95.2

1505

5760

A03FA01

ATC

metoclopramide; systemic, rectal

0.6

94.2

2400

24590

N30.0

ICD-10 Finland

Acute cystitis

1.5

91.8

3610

17444

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.8

90.4

1622

6450

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

2.3

89.9

774

2362

G04CA02

ATC

tamsulosin; oral

1.4

89.6

6760

36749

F00.24

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms of mixed type

353.2

88.6

103

193

Kela drug reimbursment

Rasagiline

4.7

84.1

222

324

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.4

83.9

673

1991

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

3.3

83.4

358

755

E86

ICD-10 Finland

Volume depletion

2.2

82.5

751

2347

S72.1

ICD-10 Finland

Pertrochanteric fracture

2.2

82.0

758

2384

AA5DR

NOMESCO Finland

Brain metabolism PET with CT

18.6

81.9

R44.1

ICD-10 Finland

Visual hallucinations

4.8

81.7

212

305

N29

ICPC

Neurological sympt/complt other

2.7

80.5

493

1279

R1250, ,

SPAT

2.3

79.7

708

2189

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.5

79.6

570

1599

F0011, G301,

ICD-10 Finland

624.8

79.6

N28

ICPC

Limited function/disability (N)

2.7

78.1

474

1224

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.2

78.0

713

2232

XF606, ,

SPAT

3.7

77.3

278

520

F00, F03,

ICD-10 Finland

+∞

76.1

B03BA03

ATC

hydroxocobalamin; parenteral

1.7

75.5

1524

6259

A27

ICPC

Fear of other disease NOS

1.8

73.3

1168

4472

3310A

ICD-9 Finland

Other cerebral degenerations, Alzheimer's disease

+∞

70.7

NFJ54

NOMESCO Finland

Internal fixation of fracture of upper femur with intramedullary nail

2.4

70.5

542

1572

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

70.4

6194

34178

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.6

70.3

1964

8761

N06AB04

ATC

citalopram; systemic

1.4

70.0

3756

19144

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.7

69.2

1561

6600

R33

ICD-10 Finland

Retention of urine

1.5

69.2

2325

10812

N04BC04

ATC

ropinirole; oral

3.2

69.2

313

683

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.6

68.8

1765

7712

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.9

68.5

900

3233

A04AA02

ATC

granisetron; systemic, transdermal

0.4

68.0

328

5763

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

0.3

67.2

161

4013

SPAT1251

SPAT

Organisation of medication

2.0

66.3

854

3046

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.6

66.1

1976

8948

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

0.3

65.5

163

3978

EB4VA, ,

NOMESCO Finland

0.5

65.2

671

8850

N17

ICPC

Vertigo/dizziness

1.4

63.4

2948

14614

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

1.8

62.5

964

3651

IHA21

NOMESCO Finland

Mini-intervention for hazardous and harmful alcohol use

12.3

62.3

F00.12

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset, other additional symptoms, mainly hallucinations

+∞

61.8

SPAT1279

SPAT

Preparation of immediate hospitalisation

2.8

61.2

343

849

J01CA08

ATC

pivmecillinam; oral

1.3

60.3

6876

39132

WX402

NOMESCO Finland

General anaesthesia

0.7

60.1

2030

19848

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.4

60.1

2989

14990

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.8

59.8

996

3863

WYA20, ,

SPAT

3.4

58.6

238

485

TQW40, ,

SPAT

0.5

58.3

760

9339

N07AA05, ,

ATC

+∞

58.2

F01

ICD-10 Finland

Vascular dementia

4.7

58.1

155

229

P05

ICPC

Senility, feeling/behaving old

3.9

57.6

190

334

WZC30

NOMESCO Finland

Teaching

0.7

57.2

1759

17540

P29

ICPC

Psychological sympt/compl other

2.0

57.2

672

2319

ZYB04, ,

SPAT

5.2

56.7

134

177

R1210, ,

SPAT

4.3

56.5

166

266

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

56.5

5911

33194

A69

ICPC

General and Unspecified, Other reason for encounter NEC

2.1

56.5

621

2091

N05AD03

ATC

melperone; systemic

2.7

56.2

343

889

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.2

56.0

550

1772

F00.21

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly paranoidism

+∞

55.5

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

55.3

3203

16470

A04AA01

ATC

ondansetron; systemic, rectal

0.5

55.2

607

7857

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.8

54.8

990

3932

H02AA02

ATC

fludrocortisone; oral

3.1

54.4

247

541

F01.3

ICD-10 Finland

Mixed cortical and subcortical vascular dementia

4.9

54.2

136

190

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.4

53.7

2823

14273

R23.8

ICD-10 Finland

Other and unspecified skin changes

0.7

53.6

2620

24032

J01EA01

ATC

trimethoprim; systemic

1.3

53.5

5223

29017

F002, G308,

ICD-10 Finland

214.8

53.2

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

0.3

52.9

177

3697

G31.9

ICD-10 Finland

Degenerative disease of nervous system, unspecified

5.5

52.8

119

150

F0024, G308,

ICD-10 Finland

+∞

52.8

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.3

52.6

4628

25337

J01DB01

ATC

cefalexin; oral

1.3

52.5

15768

100058

SPAT1014

SPAT

Treatment of eyes

2.3

52.5

450

1371

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.1

52.3

551

1826

F00.09

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset information on additional symptoms is lacking

+∞

51.9

SPAT1125

SPAT

Stoma care and guidance

2.2

51.7

489

1552

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.5

51.6

2131

10302

Z01.9

ICD-10 Finland

Special examination, unspecified

1.7

51.5

1145

4814

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.3

51.1

8052

47410

N04BX02

ATC

entacapone; oral

4.3

51.0

149

238

F02.32

ICD-10 Finland

Dementia in Parkinson's disease other additional symptoms, mainly hallucinations

28.1

49.9

SPAT1262

SPAT

Handing over of treatment supplies

1.3

49.8

3738

19985

F00.2

ICD-10 Finland

Dementia in Alzheimer disease, atypical or mixed type

203.5

49.7

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

49.5

5933

33783

WF049

NOMESCO Finland

Radiotherapy of metastasis

0.4

48.8

202

3810

NF1AA

NOMESCO Finland

Hip X-ray examination

1.4

48.8

2243

11059

SPAT1260

SPAT

Consultation of another employee

1.3

48.0

3504

18643

XF600, ,

SPAT

1.7

47.8

872

3472

S00.0

ICD-10 Finland

Superficial injury of scalp

2.0

47.1

533

1815

F02.30

ICD-10 Finland

Dementia in Parkinson's disease without additional symptoms

48.9

46.8

WX212

NOMESCO Finland

Femoral plexus blockade

1.9

46.7

598

2128

Z2445

NOMESCO Finland

Psychologist

2.3

46.5

390

1177

F05.8

ICD-10 Finland

Other delirium

2.9

45.9

237

561

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.2

45.5

9695

58751

JN4AD

NOMESCO Finland

Body CT examination

0.7

45.4

1450

14402

S01.1

ICD-10 Finland

Open wound of eyelid and periocular area

2.0

44.9

505

1715

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

2.2

44.8

394

1214

F009, F03,

ICD-10 Finland

+∞

44.7

R32

ICD-10 Finland

Unspecified urinary incontinence

1.9

44.7

667

2498

L01BC06

ATC

capecitabine; oral

0.4

44.6

193

3566

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

44.5

2851

14854

K59.0

ICD-10 Finland

Constipation

1.6

44.4

1320

5952

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

0.8

44.2

3538

30287

Z28

ICPC

Limited function/disability (Z)

3.8

44.2

152

276

F22.0

ICD-10 Finland

Delusional disorder

2.6

44.1

284

757

F00.13

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly depression

+∞

43.9

EB1VA, ,

NOMESCO Finland

0.7

43.8

1318

13257

SPAT1307

SPAT

Psychosocial counselling and guidance

2.1

43.6

481

1623

F0012, G301,

ICD-10 Finland

178.7

43.5

E0000UV, ,

ATC

1.2

43.5

7499

44367

N02AJ06

ATC

codeine and paracetamol; systemic

0.8

43.1

5320

43200

F00.22

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms, mainly hallucinations

342.1

43.1

G04CB02

ATC

dutasteride; oral

1.4

43.0

2043

10121

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.3

42.9

2930

15408

A98

ICPC

Health maint/preventive medicine

1.3

42.6

18307

119233

G04BD08

ATC

solifenacin; oral

1.5

42.5

1546

7276

F00.29

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without information on additional symptoms

335.2

42.2

R44.3

ICD-10 Finland

Hallucinations, unspecified

3.7

42.1

147

270

G25.9

ICD-10 Finland

Extrapyramidal and movement disorder, unspecified

2.5

41.7

289

799

F02.09*G31.0

ICD-10 Finland

Dementia in Pick's disease without information on additional symptoms

8.1

41.7

H25.1

ICD-10 Finland

Senile nuclear cataract

1.2

41.6

8305

49827

F0232, G20,

ICD-10 Finland

24.3

41.5

SDA04

NOMESCO Finland

Demanding periodontal treatment

0.7

41.3

2471

22072

L82

ICD-10 Finland

Seborrhoeic keratosis

0.7

41.2

2353

21168

L75

ICPC

Fracture: femur

2.2

41.1

375

1174

SPAT1276

SPAT

Outlining of treatment with patient or their family members

2.0

40.8

486

1686

W06

ICD-10 Finland

Fall involving bed

2.6

40.8

253

662

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.6

40.7

961

4100

T90.5

ICD-10 Finland

Sequelae of intracranial injury

3.0

40.5

202

469

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.4

39.7

302

873

N30.9

ICD-10 Finland

Cystitis, unspecified

1.5

39.6

1345

6240

XF606

NOMESCO Finland

Ortostatic test

2.7

39.6

240

621

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

1.8

39.4

643

2477

D12

ICPC

Constipation

1.7

39.3

879

3698

C03CA01

ATC

furosemide; systemic

1.2

38.7

9005

54732

S09.9

ICD-10 Finland

Unspecified injury of head

2.2

38.5

336

1032

C10AX09

ATC

ezetimibe; oral

0.7

38.4

2113

19139

HA1RA, ,

SPAT

0.3

38.0

128

2664

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.8

37.9

663

2607

N99

ICPC

Neurological disease other

2.4

37.9

273

770

F00.01

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly paranoidism

300.7

37.8

K59.09

ICD-10 Finland

Constipation, unspecified

1.4

37.5

1587

7689

R35

ICD-10 Finland

Polyuria

1.5

37.3

1526

7344

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

1.9

37.2

515

1883

F00.23

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly depression

293.8

36.9

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

36.4

8304

50269

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.7

36.4

736

3016

65000

ICD-8 Finland

Delivery without mention of complication, Occipital presentation

0.8

36.3

2715

23551

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

0.2

36.2

1898

OAB41, ,

SPAT

2.6

36.0

226

596

S01.8

ICD-10 Finland

Open wound of other parts of head

2.2

36.0

325

1014

F02.80

ICD-10 Finland

Dementia in another specified disease that is classified elsewhere without additional symptoms

54.9

35.9

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.3

35.9

2607

13809

A10AB05

ATC

insulin aspart; parenteral

1.5

35.8

1434

6872

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

0.5

35.6

412

5264

G46.8*I67.9

ICD-10 Finland

Other vascular syndromes of brain in cerebrovascular diseases

5.2

35.5

109

SPAT1284

SPAT

Extensive health certificate

2.0

35.3

408

1401

R11

ICD-10 Finland

Nausea and vomiting

1.4

35.2

1613

7927

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.8

34.9

575

2221

R63.4

ICD-10 Finland

Abnormal weight loss

1.6

34.7

883

3836

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.2

34.6

7629

45964

G72.8

ICD-10 Finland

Other specified myopathies

2.0

34.3

384

1303

SPAT1310

SPAT

Counselling related to known health issue

1.2

34.3

5854

34381

-2, ,

ICPC

3.2

34.3

148

315

R29.6

ICD-10 Finland

Tendency to fall, not elsewhere classified

3.1

34.1

155

341

WPA10, ,

SPAT

4.1

34.0

105

176

F0021, G308,

ICD-10 Finland

+∞

34.0

C03DA01

ATC

spironolactone; oral

0.7

33.9

1935

17458

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.4

33.9

1961

10027

XQ855, ,

SPAT

2.4

33.8

258

748

Y94.0

ICD-10 Finland

Accident at home

2.0

33.7

404

1406

LAITO, ,

NOMESCO Finland

8.3

33.6

F01.80

ICD-10 Finland

Other specified vascular dementia without additional symptoms

7.5

33.2

R25.1

ICD-10 Finland

Tremor, unspecified

1.7

33.2

633

2553

OAB43, ,

SPAT

0.4

33.1

158

2795

S28

ICPC

Limited function/disability (S)

2.7

33.1

190

478

A06AC01

ATC

ispaghula (psylla seeds); oral

1.2

32.9

5391

31507

N80

ICPC

Head injury other

2.0

32.8

383

1321

SPAT1138

SPAT

Guidance concerning bowel function

2.1

32.6

336

1106

WZC00

NOMESCO Finland

Treatment plan or consultation

0.8

32.4

4894

39182

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.3

32.2

2564

13742

K08.3

ICD-10 Finland

Retained dental root

1.4

32.0

1429

6988

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.2

32.0

4649

26815

Z03

ICPC

Housing/neighbourhood problem

3.2

32.0

140

301

F01.24

ICD-10 Finland

Subcortical vascular dementia other additional symptoms of mixed type

6.4

31.8

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

0.7

31.7

1447

13538

SPAT1244

SPAT

Occupational therapy

2.5

31.7

219

606

L03AA13

ATC

pegfilgrastim; parenteral

0.4

31.6

225

3383

F10.73

ICD-10 Finland

Residual or late-onset psychosis caused by alcohol dementia

5.0

31.2

104

2900A

ICD-9 Finland

Senile and presenile organic psychotic conditions, Senile dementia, uncomplicated

4.8

31.1

115

F00.04

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms of mixed type

245.6

30.7

UGC12

NOMESCO Finland

Flexible bronchoscopy

0.7

30.4

955

9557

F0230, G20,

ICD-10 Finland

36.9

30.1

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

0.4

30.1

127

2373

R74

ICPC

Upper respiratory infection acute

0.8

30.1

2244

19524

S22.3

ICD-10 Finland

Fracture of rib

1.4

30.0

1329

6489

S32.8

ICD-10 Finland

Fracture of other and unspecified parts of lumbar spine and pelvis

2.2

29.8

285

911

UKC02

NOMESCO Finland

Cystoscopy

1.2

29.6

3949

22538

R54

ICD-10 Finland

Senility

2.7

29.5

169

425

F01.34

ICD-10 Finland

Mixed cortical and subcortical vascular dementia are other mixed symptoms of mixed type

7.3

29.5

F05.0

ICD-10 Finland

Delirium not superimposed on dementia, so described

3.4

29.4

118

240

N06AX21

ATC

duloxetine; oral

1.4

29.4

1639

8324

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.1

29.3

289

935

WW500

NOMESCO Finland

Blood transfusion

0.5

29.3

299

3971

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

1.5

29.1

847

3798

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

1.8

29.0

487

1893

XX3DW

NOMESCO Finland

Time consuming IT work

0.7

29.0

1182

11279

S01.9

ICD-10 Finland

Open wound of head, part unspecified

2.0

29.0

338

1166

G21.9

ICD-10 Finland

Secondary parkinsonism, unspecified

3.5

28.9

111

219

SAD02

NOMESCO Finland

Assessment of need for oral health care, extensive

1.9

28.9

408

1503

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.0

28.8

349

1220

R45.1

ICD-10 Finland

Restlessness and agitation

5.0

28.7

F0024, G301,

ICD-10 Finland

+∞

28.6

SPAT1281

SPAT

Other administrative function

1.4

28.5

1334

6574

ZX120

NOMESCO Finland

Intravenous

0.7

28.5

961

9491

ZXY02

NOMESCO Finland

Neuropsychologist

4.3

28.5

130

Z13.3

ICD-10 Finland

Special screening examination for mental and behavioural disorders

7.3

28.4

XQ858, ,

SPAT

2.8

28.3

155

381

N04BC09

ATC

rotigotine; transdermal

3.6

28.2

105

203

A04AA55

ATC

palonosetron, combinations; systemic

0.3

28.1

1802

F0013, G301,

ICD-10 Finland

224.9

28.1

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.5

28.0

296

3890

W0A10, ,

SPAT

12.0

28.0

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

27.9

6974

42275

H02AB06

ATC

prednisolone; systemic

0.8

27.9

7799

59257

S06.3

ICD-10 Finland

Focal brain injury

2.2

27.8

257

811

F01.23

ICD-10 Finland

Subcortical vascular dementia other additional symptoms, mainly depression

8.4

27.7

Z51.5

ICD-10 Finland

Palliative care

1.3

27.6

2239

12016

A01

ICPC

Pain general/multiple sites

1.3

27.6

1874

9809

N06AX16

ATC

venlafaxine; oral

1.4

27.4

1551

7891

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.4

27.2

1215

5937

B01AB10

ATC

tinzaparin; parenteral

0.7

27.1

1144

10859

N19

ICPC

Speech disorder

2.1

27.1

285

946

A10BJ06

ATC

semaglutide; parenteral

0.5

27.0

218

3131

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

0.8

26.9

3861

31188

SPAT1325

SPAT

Vaccination

1.2

26.9

7468

45644

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

26.8

8919

55317

SDA03

NOMESCO Finland

Periodontal treatment

0.8

26.7

4246

33963

SPAT1104

SPAT

Monitoring of emergency patient

1.4

26.7

1237

6085

N03AE01

ATC

clonazepam; systemic

1.5

26.6

909

4219

G04CA01

ATC

alfuzosin; oral

1.3

26.3

2776

15400

F06.0

ICD-10 Finland

Organic hallucinosis

4.3

26.3

121

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.2

26.3

3265

18463

WZA30

NOMESCO Finland

Assessment of driving capacity and statement

15.3

26.0

G04BD07

ATC

tolterodine; oral

1.4

26.0

1091

5270

SPAT1157

SPAT

Guidance concerning treatment of mouth and mucous membranes

2.2

26.0

249

797

S01.41

ICD-10 Finland

Open wound in the temple-jaw region

2.4

25.9

200

584

F32

ICD-10 Finland

Depressive episode

1.7

25.9

503

2041

R4120, ,

SPAT

2.1

25.8

258

840

K90

ICPC

Stroke/cerebrovascular accident

1.6

25.6

699

3090

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

0.5

25.4

212

3010

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.5

25.2

909

4264

WF002

NOMESCO Finland

Radical radiotherapy

0.6

25.2

582

6212

SPAT1285

SPAT

Provision of consultation response

1.5

25.2

952

4509

N02AX02

ATC

tramadol; systemic, rectal

0.8

25.1

6913

52751

S20.2

ICD-10 Finland

Contusion of thorax

1.5

25.1

850

3937

Z60.8

ICD-10 Finland

Other problems related to social environment

3.7

25.1

160

F0004, G300,

ICD-10 Finland

+∞

25.1

N04BC05

ATC

pramipexole; oral

1.4

25.0

1487

7623

R01AD59

ATC

mometasone, combinations; nasal

0.4

24.9

139

2297

I95.9

ICD-10 Finland

Hypotension, unspecified

1.9

24.9

349

1284

J01MA02

ATC

ciprofloxacin; systemic

1.2

24.7

8024

49569

P03

ICPC

Feeling depressed

1.5

24.5

813

3750

L03AA02

ATC

filgrastim; parenteral

0.4

24.4

154

2423

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.5

24.4

845

3933

J01.0

ICD-10 Finland

Acute maxillary sinusitis

0.8

24.4

1848

16084

N03AX14

ATC

levetiracetam; systemic

1.7

24.2

477

1942

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

3.0

24.2

115

261

AAD10

NOMESCO Finland

Evacuation of chronic subdural haematoma

1.9

24.0

337

1240

JN4BD

NOMESCO Finland

Extensive body CT

0.7

23.9

1341

12174

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

0.7

23.6

641

6612

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

1.4

23.6

943

4514

A10BK03

ATC

empagliflozin; oral

0.7

23.6

1199

11048

T08

ICPC

Weight loss

1.9

23.5

335

1239

J96.1

ICD-10 Finland

Chronic respiratory failure

0.5

23.5

168

2520

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

0.4

23.4

125

2104

R03AK07

ATC

formoterol and budesonide; inhalant

0.8

23.4

1932

16640

E000001, ,

ATC

1.2

23.4

3086

17545

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

0.6

23.3

558

5909

F009, G301,

ICD-10 Finland

+∞

23.3

XKD00

NOMESCO Finland

Uroflowmetry

1.2

23.0

3848

22414

IHA10

NOMESCO Finland

Structured mapping of problematic alcohol use

2.6

22.9

143

378

SPAT1352

SPAT

Inspection, maintenance and instruction for use of hearing aid

1.8

22.8

361

1381

F0022, G308,

ICD-10 Finland

185.5

22.8

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.2

22.7

2772

15624

SPAT1127

SPAT

Enema

2.2

22.7

200

620

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

0.3

22.5

1316

L76

ICPC

Fracture: other

1.6

22.5

625

2775

GD1AA, ,

SPAT

0.7

22.4

876

8429

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.2

22.4

6169

37536

X59

ICD-10 Finland

Exposure to unspecified factor

1.2

22.4

2991

17022

K91

ICPC

Cerebrovascular disease

1.8

22.3

325

1211

G31.1

ICD-10 Finland

Senile degeneration of brain, not elsewhere classified

5.1

22.3

F06.9

ICD-10 Finland

Unspecified mental disorder due to brain damage and dysfunction and to physical disease

4.0

22.2

120

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

0.2

22.2

960

Z10.1

ICD-10 Finland

Routine general health check-up of inhabitants of institutions

6.7

22.2

S01BC05

ATC

ketorolac; ophthalmic

1.4

22.1

877

4193

K03.64

ICD-10 Finland

Dental calculus supragingival

0.8

22.0

2912

23793

A11CC03

ATC

alfacalcidol; systemic

0.4

22.0

132

2117

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.3

22.0

2463

13744

I68.0*E85.9

ICD-10 Finland

Cerebral amyloid angiopathy

4.7

21.9

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.5

21.9

710

3260

EBA30

NOMESCO Finland

Extraction of root of tooth

1.4

21.9

1012

4976

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.5

21.9

676

3073

M01AH05

ATC

etoricoxib; oral

0.9

21.9

8112

60726

F01.10

ICD-10 Finland

Multi-infarct dementia without additional symptoms

3.5

21.8

157

N95.2

ICD-10 Finland

Postmenopausal atrophic vaginitis

0.7

21.7

578

5985

A10AE04

ATC

insulin glargine; parenteral

1.3

21.7

1791

9622

NG1AA, ,

SPAT

0.5

21.7

234

3051

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

0.7

21.7

987

9258

C04AE01

ATC

ergoloid mesylates; systemic

2.3

21.6

171

506

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

0.6

21.6

558

5813

R18

ICD-10 Finland

Ascites

0.4

21.4

1710

KED22

NOMESCO Finland

Transurethral resection of prostate

1.3

21.4

1512

7950

P28

ICPC

Limited function/disability (P)

2.9

21.4

109

258

R45.5

ICD-10 Finland

Hostility

9.8

21.3

G04BD09

ATC

trospium; oral

1.6

21.3

516

2218

N05AX12

ATC

aripiprazole; systemic

2.1

21.2

218

719

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

0.8

21.0

1729

14905

ZX120, ,

SPAT

1.9

20.9

269

963

F00.0

ICD-10 Finland

Dementia in Alzheimer disease with early onset

89.1

20.8

JAB30

NOMESCO Finland

Repair of inguinal hernia using prosthetic material

1.3

20.7

2165

11978

SPAT1236

SPAT

Informing family of child’s disability

1.8

20.7

348

1356

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

0.8

20.6

3060

24733

F0023, G308,

ICD-10 Finland

+∞

20.6

SPAT1240

SPAT

Therapeutic discussion

1.4

20.6

932

4566

TPX10

NOMESCO Finland

Implantation of vascular injection port

0.5

20.5

156

2287

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

3.1

20.4

213

N05AH02

ATC

clozapine; systemic

2.7

20.4

119

304

IBZ07

NOMESCO Finland

Neurological assessment in psychiatry

4.5

20.4

Y94.1

ICD-10 Finland

Accident in connection with service housing

6.2

20.3

P04

ICPC

Feeling/behaving irritable/angry

3.8

20.3

122

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

0.4

20.3

114

1875

G40

ICD-10 Finland

Epilepsy

2.6

20.2

130

349

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

1.6

20.1

503

2181

S00.9

ICD-10 Finland

Superficial injury of head, part unspecified

2.0

20.0

225

768

SPAT1313

SPAT

Guidance and counselling related to accident prevention

2.6

20.0

122

319

SPAT1081

SPAT

Cardiorespiratory global assessment

1.4

20.0

1166

5959

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

1.9

19.9

283

1048

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

0.5

19.8

146

2163

WF004

NOMESCO Finland

Palliative radiotherapy

0.5

19.7

143

2132

N03AF02

ATC

oxcarbazepine; oral

1.6

19.7

463

1976

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

0.6

19.7

358

4039

E66.01

ICD-10 Finland

Obesity due to excess calories

0.6

19.6

395

4348

F01.8

ICD-10 Finland

Other vascular dementia

4.6

19.4

201

Kela drug reimbursment

Chronic cardiac insufficiency

0.7

19.4

912

8514

S42.2

ICD-10 Finland

Fracture of upper end of humerus

1.4

19.4

923

4562

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.5

19.3

590

2678

GD1AD

NOMESCO Finland

Thorax CT examination

0.7

19.3

685

6706

R40.2

ICD-10 Finland

Coma, unspecified

2.2

19.2

177

560

F02.34

ICD-10 Finland

Dementia in Parkinson's disease, other additional symptoms of mixed type

37.0

19.1

A78

ICPC

Infectious disease other/NOS

2.1

19.1

193

633

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

0.6

19.1

326

3737

L15

ICPC

Knee symptom/complaint

0.8

19.1

3294

26280

SPAT1097

SPAT

Recording of ECG

1.2

19.1

3017

17445

P18

ICPC

Medication abuse

3.3

19.1

165

4912B

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]

0.2

19.0

953

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

0.3

19.0

1335

F09

ICD-10 Finland

Unspecified organic or symptomatic mental disorder

5.4

19.0

C10AA07

ATC

rosuvastatin; oral

0.9

18.9

4893

37745

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

0.5

18.9

171

2358

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

0.4

18.9

106

1743

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

1.9

18.9

262

963

AA5EN

NOMESCO Finland

Brain reseptor or transprot protein distribution isotope imaging

3.0

18.9

209

M04AA01

ATC

allopurinol; systemic

0.8

18.8

2344

19302

F01.39

ICD-10 Finland

Mixed cortical and subcortical vascular dementia without information on additional symptoms

4.4

18.8

N07AA06, ,

ATC

+∞

18.8

U13

ICPC

Bladder symptom/complaint other

1.5

18.8

548

2462

K02.0

ICD-10 Finland

Caries limited to enamel

0.8

18.6

1253

11095

S00.1

ICD-10 Finland

Contusion of eyelid and periocular area

1.8

18.6

313

1222

A69.2

ICD-10 Finland

Lyme disease

0.7

18.5

496

5127

C01DA14

ATC

isosorbide mononitrate; oral

1.2

18.5

4567

27469

S00.8

ICD-10 Finland

Superficial injury of other parts of head

1.8

18.4

291

1115

A10BH05

ATC

linagliptin; oral

1.3

18.4

1187

6161

XF600

NOMESCO Finland

Bloodpressure measurement

1.3

18.3

1143

5901

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

0.6

18.3

278

3283

B01AA03

ATC

warfarin; systemic

1.2

18.3

5121

31102

R03AC02

ATC

salbutamol; inhalant

0.9

18.2

7863

58520

F0020, G301,

ICD-10 Finland

78.8

18.2

A10BK01

ATC

dapagliflozin; oral

0.7

18.2

865

8063

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

2.1

17.9

184

608

AA1ED

NOMESCO Finland

Trauma CT of head and neck

2.5

17.8

121

334

ZYC01, ,

SPAT

1.3

17.7

1344

7134

R06.0

ICD-10 Finland

Dyspnoea

0.9

17.7

4625

35681

S01

ICD-10 Finland

Open wound of head

2.0

17.7

216

761

T05

ICPC

Feeding problem of adult

2.5

17.6

115

312

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

0.8

17.6

1266

11114

HA1RA

NOMESCO Finland

Combined assessment of mammary gland (mammography and ultrasound)

0.4

17.5

103

1662

F00.02

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly illusions

143.9

17.5

R01AD58

ATC

fluticasone, combinations; nasal

0.8

17.5

1720

14539

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.2

17.5

1997

11154

Z00.0

ICD-10 Finland

General medical examination

1.2

17.4

3422

20171

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

0.4

17.4

1529

U29

ICPC

Urinary symptom/complaint other

1.5

17.3

604

2818

KMAK, ,

NOMESCO Finland

1.1

17.3

6987

43538

AA1AG, ,

SPAT

6.6

17.2

R2110

NOMESCO Finland

Giving the first information

1.4

17.2

839

4165

U28

ICPC

Limited function/disability (U)

1.9

17.2

237

870

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

1.9

17.2

216

769

S42.0

ICD-10 Finland

Fracture of clavicle

1.6

17.1

394

1674

AAA20

NOMESCO Finland

Insertion of intraventricular pressure monitoring device

3.9

17.1

HA1AA, ,

SPAT

0.4

17.1

1578

N04AA02

ATC

biperiden; systemic

1.9

17.1

236

867

XKD06

NOMESCO Finland

Physiologic investigation of micturition

1.5

17.1

543

2486

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

2.0

17.0

196

676

F0019, G309,

ICD-10 Finland

+∞

17.0

G91.0

ICD-10 Finland

Communicating hydrocephalus

2.6

16.9

107

286

I67.4

ICD-10 Finland

Hypertensive encephalopathy

5.5

16.8

IAB14

NOMESCO Finland

Geriatric psychiatry consultation

3.5

16.8

120

M25.5

ICD-10 Finland

Pain in joint

0.8

16.8

3601

28235

H91.1

ICD-10 Finland

Presbycusis

1.3

16.7

1804

10008

B81

ICPC

Anaemia vit B12/folate deficiency

1.4

16.7

803

3975

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

1.7

16.7

326

1327

T03

ICPC

Loss of appetite

2.8

16.7

221

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

1.9

16.7

229

840

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

1.7

16.7

315

1272

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

0.6

16.7

321

3569

N18

ICPC

Paralysis/weakness

1.6

16.6

400

1719

F02.8

ICD-10 Finland

Dementia in other specified diseases classified elsewhere

137.0

16.6

D19

ICPC

Teeth/gum symptom/complaint

0.8

16.5

2978

23703

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

1.9

16.4

207

738

ZYY02, ,

SPAT

6.3

16.4

WX302

NOMESCO Finland

Thoracal epidural anesthesy

0.7

16.4

475

4833

A99

ICPC

Disease/condition unspecnature/site

1.2

16.4

1857

10362

D70.82

ICD-10 Finland

Drug-induced neutropenia

0.3

16.4

1157

HA1AA

NOMESCO Finland

X-ray mammography

0.7

16.3

713

6738

S82

ICPC

Naevus/mole

0.8

16.3

1524

12958

C10AA02

ATC

lovastatin; oral

1.4

16.3

953

4874

A10BB12

ATC

glimepiride; oral

1.3

16.2

1635

9004

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

0.7

16.1

926

8390

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.3

16.1

1355

7293

F0021, G301,

ICD-10 Finland

+∞

16.1

F00.03

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenil onset other additional symptoms, mainly depression

+∞

16.1

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

0.4

16.1

101

1585

R31

ICD-10 Finland

Unspecified haematuria

1.2

15.9

2386

13706

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

2.1

15.9

152

489

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

1.7

15.9

293

1176

A12AA04

ATC

calcium carbonate; oral

0.4

15.9

1302

TK800

NOMESCO Finland

Hemodialysis

0.4

15.8

106

1624

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

0.4

15.8

1200

Q90.9

ICD-10 Finland

Down syndrome, unspecified

130.1

15.8

EBA00

NOMESCO Finland

Extraction of tooth

1.1

15.7

5582

34425

F02.3

ICD-10 Finland

Dementia in Parkinson disease

68.5

15.6

M02AA07

ATC

piroxicam; topical

1.1

15.6

6957

43554

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.4

15.6

669

3248

D25.9

ICD-10 Finland

Leiomyoma of uterus, unspecified

0.7

15.6

401

4180

D07AA02

ATC

hydrocortisone; topical

1.2

15.6

1917

10790

250, ,

Kela drug reimbursment

0.5

15.6

178

2275

SPAT1255

SPAT

Intravenous administration of medicine

1.3

15.6

1202

6398

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

0.3

15.5

1096

GD1QA, ,

SPAT

3.2

15.5

141

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

0.6

15.3

255

2939

OAB48, ,

SPAT

0.6

15.3

231

2729

A08.1

ICD-10 Finland

Acute gastroenteropathy due to Norovirus

2.7

15.2

213

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.3

15.2

1344

7280

NF3AA

NOMESCO Finland

Femur X-ray examination

1.5

15.2

429

1916

S01.2

ICD-10 Finland

Open wound of nose

1.8

15.1

243

937

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.4

15.1

781

3916

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

1.5

15.1

434

1946

L01CA04

ATC

vinorelbine; systemic

0.2

15.0

729

F01.19

ICD-10 Finland

Multi-infarct dementia without information on additional symptoms

2.9

15.0

173

G04BD10

ATC

darifenacin; oral

2.2

15.0

140

447

F22.9

ICD-10 Finland

Persistent delusional disorder, unspecified

2.6

14.9

251

U05

ICPC

Urination problems other

1.3

14.9

1110

5879

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

3.1

14.9

148

Z08

ICPC

Social welfare problem

2.0

14.9

161

544

T93

ICPC

Lipid disorder

0.7

14.8

783

7180

F01.21

ICD-10 Finland

Subcortical vascular dementia without additional symptoms, mainly paranoidism

6.2

14.8

Z02.8

ICD-10 Finland

Other examinations for administrative purposes

2.2

14.7

124

379

OAA80, ,

SPAT

0.2

14.7

788

Z11

ICPC

Compliance/being ill problem

2.3

14.7

117

349

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

0.7

14.7

477

4746

G47.3

ICD-10 Finland

Sleep apnoea

0.8

14.7

2476

19842

S32.5

ICD-10 Finland

Fracture of pubis

1.9

14.6

201

738

TPH04, ,

SPAT

1.9

14.6

202

743

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

0.7

14.6

532

5186

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.2

14.6

2958

17460

G23.9

ICD-10 Finland

Degenerative disease of basal ganglia, unspecified

3.1

14.6

150

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.1

14.6

6345

39623

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.4

14.5

814

4136

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

0.7

14.5

407

4166

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.2

14.5

4373

26633

359

Kela drug reimbursment

Mirabegroni

2.2

14.5

125

386

Z75.0

ICD-10 Finland

Medical services not available in home

3.1

14.5

140

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

0.3

14.5

846

PJA12

NOMESCO Finland

Sentinel node biopsy

0.7

14.4

726

6707

SPAT1042

SPAT

Guidance concerning balance maintenance

2.3

14.4

113

335

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

0.5

14.3

165

2101

B01AC07

ATC

dipyridamole; systemic

1.3

14.2

1195

6430

C09AA05

ATC

ramipril; oral

1.1

14.2

5805

36092

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

0.3

14.2

825

S01.7

ICD-10 Finland

Multiple open wounds of head

2.2

14.1

122

377

N04BX04

ATC

opicapone; oral

3.3

14.1

121

A07

ICPC

Coma

2.5

14.1

250

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

0.3

14.1

823

F02.82

ICD-10 Finland

Dementia in other specified disease that is classified elsewhere other symptoms, mainly hallucinations

34.2

14.1

I68.0

ICD-10 Finland

Cerebral amyloid angiopathy

6.4

14.1

L03AA14

ATC

lipegfilgrastim; parenteral

0.4

14.0

1082

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

0.2

14.0

740

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

0.2

14.0

671

D17

ICPC

Incontinence of bowel

1.8

13.9

215

820

Angiography of the heart and coronary arteries

1.2

13.9

1567

8737

WVA40, ,

SPAT

2.2

13.9

128

407

L02BG04

ATC

letrozole; oral

0.7

13.9

554

5311

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

0.3

13.8

846

-1, ,

ICPC

1.4

13.8

559

2687

Z43.5

ICD-10 Finland

Attention to cystostomy

2.0

13.8

157

541

G04BX04, ,

ATC

1.6

13.8

328

1409

S01.3

ICD-10 Finland

Open wound of ear

1.8

13.7

201

754

Z20.8

ICD-10 Finland

Contact with and exposure to other communicable diseases

1.5

13.7

410

1855

Z60.9

ICD-10 Finland

Problem related to social environment, unspecified

3.1

13.7

138

S52.5

ICD-10 Finland

Fracture of lower end of radius

1.2

13.6

1703

9600

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.5

13.6

402

1814

G23.1

ICD-10 Finland

Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]

3.2

13.6

124

SPAT1394

SPAT

Counselling and guidance related to living conditions

2.9

13.5

157

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.6

13.5

347

1517

N04BB01

ATC

amantadine; oral

1.7

13.5

234

924

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

2.4

13.5

285

F000, G300,

ICD-10 Finland

+∞

13.4

128

Kela drug reimbursment

Cancers of female genital organs

0.4

13.4

1278

W10

ICD-10 Finland

Fall on and from stairs and steps

1.3

13.4

832

4296

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

0.8

13.3

1826

14927

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

2.5

13.3

233

J01FA09

ATC

clarithromycin; systemic

0.9

13.3

3455

26759

F02.84

ICD-10 Finland

Dementia in another specified disease that is classified elsewhere as other mixed symptoms of mixed type

32.5

13.3

WF003

NOMESCO Finland

Adjuvant radiotherapy

0.6

13.2

267

2932

NB6AA

NOMESCO Finland

Humerus X-ray examination

1.5

13.2

397

1799

C25.1

ICD-10 Finland

Malignant neoplasm: Body of pancreas

0.1

13.2

380

R4130, ,

SPAT

2.5

13.2

230

S06.6

ICD-10 Finland

Traumatic subarachnoid haemorrhage

1.8

13.2

187

695

U08

ICPC

Urinary retention

1.5

13.1

458

2141

Z74.1

ICD-10 Finland

Need for assistance with personal care

7.5

13.1

L01CB01

ATC

etoposide; systemic

0.1

13.1

376

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

1.2

13.0

1637

9233

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.4

13.0

593

2913

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

3.9

13.0

4289X

ICD-9 Finland

Heart failure, unspecified

0.2

13.0

568

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.3

13.0

104

312

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.2

12.9

1731

9827

I64

ICD-10 Finland

Stroke, not specified as haemorrhage or infarction

2.0

12.9

153

536

SDA05

NOMESCO Finland

Very demanding periodontal treatment

0.7

12.9

402

4026

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

2.4

12.8

254

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

2.0

12.7

134

449

Z51.88

ICD-10 Finland

Other specified medical care

1.5

12.7

357

1594

F01.22

ICD-10 Finland

Subcortical vascular dementia with additional symptoms, mainly hallucinations

5.5

12.7

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

0.2

12.7

642

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.4

12.7

715

3637

G23.8

ICD-10 Finland

Other specified degenerative diseases of basal ganglia

4.2

12.7

B03XA02

ATC

darbepoetin alfa; parenteral

0.5

12.7

156

1948

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.3

12.6

920

4860

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

0.5

12.6

1379

D64.9

ICD-10 Finland

Anaemia, unspecified

1.2

12.6

2629

15550

XJH00

NOMESCO Finland

Transanal ultrasonography

1.2

12.6

1395

7763

F0022, G301,

ICD-10 Finland

+∞

12.5

F0001, G300,

ICD-10 Finland

+∞

12.5

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.3

12.5

759

3906

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

0.6

12.4

225

2534

D22

ICD-10 Finland

Melanocytic naevi

0.6

12.4

205

2362

115

Kela drug reimbursment

Breast cancer

0.8

12.4

820

7284

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

1.6

12.4

330

1457

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.3

12.4

1159

6324

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

0.5

12.3

127

1672

F0280, G318,

ICD-10 Finland

19.6

12.3

N88

ICPC

Epilepsy

2.4

12.3

255

N02BF01

ATC

gabapentin; oral

0.8

12.3

1073

9205

N05CD07

ATC

temazepam; oral

1.2

12.3

2590

15328

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

0.2

12.3

557

IGV01

NOMESCO Finland

Psychiatric network contact

3.0

12.2

137

PA7BD

NOMESCO Finland

CT angiography of neck and brain

1.6

12.1

265

1115

J01FA10

ATC

azithromycin; systemic

0.9

12.1

6906

50949

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

0.9

12.1

5218

39122

N07

ICPC

Convulsion/seizure

3.7

12.1

6500B

ICD-9 Finland

Delivery in a completely normal case[PARTUS SINE COMPLICATIONE]

0.7

12.1

321

3320

Z73.6

ICD-10 Finland

Limitation of activities due to disability

1.9

12.1

146

515

WZC30, ,

SPAT

0.8

12.1

873

7664

TAA40

NOMESCO Finland

Cathetrisation of cerebrospinal fluid through skin

3.1

12.1

123

I50.1

ICD-10 Finland

Left ventricular failure

0.8

12.1

778

6934

S22.4

ICD-10 Finland

Multiple fractures of ribs

1.5

12.1

375

1713

V252A

ICD-9 Finland

Contraceptive management, Sterilisation

0.7

12.1

553

5181

A06

ICPC

Fainting/syncope

1.7

12.0

251

1044

SPAT1142

SPAT

Minor procedure on teeth, gums, mouth and pharynx

3.2

12.0

109

N05AB03

ATC

perphenazine; systemic, rectal

1.5

12.0

400

1853

ZYY02

NOMESCO Finland

Contact between professionals and family members

6.1

12.0

W18

ICD-10 Finland

Other fall on same level

2.2

12.0

107

336

-31

ICPC

Medical examin/health eval partial

1.3

12.0

1185

6506

R4190

NOMESCO Finland

Nutritional therapy

0.6

12.0

180

2125

B01AC04

ATC

clopidogrel; oral

1.1

12.0

3955

24201

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

1.8

12.0

191

737

P99

ICPC

Psychological disorders other

1.7

11.9

211

839

I69.8

ICD-10 Finland

Sequelae of other and unspecified cerebrovascular diseases

2.1

11.9

116

378

G46.8

ICD-10 Finland

Other vascular syndromes of brain in cerebrovascular diseases

6.3

11.9

XX2RW, ,

NOMESCO Finland

0.4

11.8

972

G04BD11

ATC

fesoterodine; oral

1.4

11.8

558

2759

D82

ICPC

Teeth/gum disease

0.9

11.8

3855

29417

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

0.7

11.8

536

5026

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

1.7

11.7

238

983

G03CA04

ATC

estriol; systemic, vaginal

1.2

11.7

1488

8401

AA1AA

NOMESCO Finland

Head X-ray examination

1.9

11.7

145

516

D51.9

ICD-10 Finland

Vitamin B12deficiency anaemia, unspecified

1.6

11.7

247

1031

K03.66

ICD-10 Finland

Tooth plaque

1.3

11.7

1115

6097

G03DC02

ATC

norethisterone; oral

0.8

11.7

869

7600

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

2.1

11.6

110

354

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

0.5

11.6

1376

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

1.4

11.6

523

2565

F0002, G300,

ICD-10 Finland

+∞

11.6

F009, G308,

ICD-10 Finland

+∞

11.6

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

0.8

11.6

793

7010

E53.8

ICD-10 Finland

Deficiency of other specified B group vitamins

2.0

11.5

125

424

IHZ01, ,

SPAT

2.4

11.5

246

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

0.3

11.5

807

ZYY01, ,

SPAT

2.7

11.5

161

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

1.9

11.4

138

487

Y94.8

ICD-10 Finland

Other leisure activity accident

1.5

11.4

374

1728

S32.7

ICD-10 Finland

Multiple fractures of lumbar spine and pelvis

1.8

11.4

187

728

SPF30

NOMESCO Finland

Relining of denture

1.5

11.4

359

1645

D07AC01

ATC

betamethasone; topical

1.1

11.3

6304

39810

C34.16

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma

0.1

11.3

312

G03AC03

ATC

levonorgestrel; oral, implant

0.7

11.3

351

3515

N06AX12

ATC

bupropion; oral

1.5

11.2

358

1646

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

0.6

11.2

206

2308

A06AH03

ATC

naloxegol; oral

0.4

11.2

1112

R03AK03

ATC

[U] fenoterol and ipratropium bromide

0.8

11.2

843

7359

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.3

11.1

1001

5435

L04AA06

ATC

mycophenolic acid; systemic

0.4

11.1

946

I10

ICD-10 Finland

Essential (primary) hypertension

1.1

11.1

14266

94026

T82

ICPC

Obesity

0.5

11.1

122

1573

Z01.8

ICD-10 Finland

Other specified special examinations

1.1

11.1

3767

23079

R5130, ,

SPAT

2.2

11.1

298

N31.1

ICD-10 Finland

Reflex neuropathic bladder, not elsewhere classified

2.1

11.1

106

343

A05

ICPC

Feeling ill

1.4

11.1

633

3230

SPAT1111

SPAT

Planning of analgesia

1.8

11.0

183

715

SGB30

NOMESCO Finland

Other complicated root filling

0.7

10.9

455

4329

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

0.4

10.9

1045

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.4

10.9

536

2670

R50.9

ICD-10 Finland

Fever, unspecified

1.2

10.9

2529

15076

Z51.4

ICD-10 Finland

Preparatory care for subsequent treatment, not elsewhere classified

1.8

10.9

179

698

G21.8

ICD-10 Finland

Other secondary parkinsonism

3.1

10.9

109

WX290

NOMESCO Finland

Other blockage of nerve

0.9

10.9

4499

33852

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

0.3

10.9

774

OAB95, ,

SPAT

0.3

10.9

690

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

1.5

10.8

395

1865

IGP01

NOMESCO Finland

Psychiatric family contact

2.9

10.8

124

TGC00

NOMESCO Finland

Bronchial lavation

0.6

10.8

206

2287

N04BC06

ATC

cabergoline; oral

2.6

10.7

175

AA3AD

NOMESCO Finland

CT of face

1.9

10.7

138

498

S52.6

ICD-10 Finland

Fracture of lower end of both ulna and radius

1.5

10.7

300

1341

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

0.6

10.7

206

2283

L02BG06

ATC

exemestane; oral

0.5

10.7

1150

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

0.7

10.7

489

4579

F38

ICPC

Eye, Other laboratory test NEC

0.5

10.7

114

1480

WYA30, ,

SPAT

2.2

10.7

277

A04AD12

ATC

aprepitant; systemic

0.4

10.6

1063

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

0.4

10.6

776

NG1BG, ,

SPAT

0.3

10.6

724

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.1

10.6

3889

23950

R1420, ,

SPAT

2.1

10.5

104

341

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

0.7

10.5

361

3549

D07AB02

ATC

hydrocortisone butyrate; topical

1.1

10.5

4841

30224

OAB73, ,

SPAT

2.4

10.5

223

AA1FD

NOMESCO Finland

Trauma CT of head and face

3.4

10.5

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

0.8

10.4

1180

9838

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

0.4

10.4

779

D21

ICPC

Swallowing problem

1.5

10.4

285

1268

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

0.8

10.4

1241

10291

H04AA01

ATC

glucagon; nasal, parenteral

1.8

10.4

153

577

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.2

10.4

1877

10959

ZYY79, ,

SPAT

2.1

10.4

316

R00.2

ICD-10 Finland

Palpitations

0.8

10.4

625

5620

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

0.9

10.4

2771

21458

B04AB02, ,

ATC

1.4

10.4

427

2064

S21

ICPC

Skin texture symptom/complaint

0.9

10.3

2141

16898

K03.00

ICD-10 Finland

Approximal wear

0.7

10.3

498

4626

Z60.2

ICD-10 Finland

Living alone

4.6

10.3

C10AA04

ATC

fluvastatin; oral

1.2

10.3

1944

11392

WX723

NOMESCO Finland

CPAP therapy

0.6

10.3

225

2421

R053, ,

ICD-10 Finland

0.6

10.3

133

1631

A10AE05

ATC

insulin detemir; parenteral

1.3

10.3

799

4262

N39.9

ICD-10 Finland

Disorder of urinary system, unspecified

1.5

10.2

295

1328

SPAT1063

SPAT

Suctioning of mucus from airways

3.4

10.2

M76.6

ICD-10 Finland

Achilles tendinitis

0.7

10.2

316

3165

F01.0

ICD-10 Finland

Vascular dementia of acute onset

2.7

10.2

144

N18.0

ICD-10 Finland

End-stage renal disease

0.4

10.2

929

I25

ICD-10 Finland

Chronic ischaemic heart disease

1.3

10.2

1061

5865

R44.0

ICD-10 Finland

Auditory hallucinations

2.4

10.2

205

K80

ICPC

Cardiac arrhythmia NOS

0.8

10.2

1091

9145

H40.10

ICD-10 Finland

Capsular glaucoma with pseudoexfoliation on the anterior lens capsule

1.3

10.1

618

3189

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.2

10.1

1374

7816

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

0.5

10.1

1189

F02.31

ICD-10 Finland

Dementia in Parkinson's disease other additional symptoms, mainly paranoidism

25.7

10.1

F32.0

ICD-10 Finland

Mild depressive episode

1.6

10.0

234

1004

AAG20

NOMESCO Finland

Stereotactic intracranial implantation of electrodes

3.3

10.0

Z51.0

ICD-10 Finland

Radiotherapy session

0.5

10.0

1083

N84.0

ICD-10 Finland

Polyp of corpus uteri

0.7

9.9

548

4989

D06BB10

ATC

imiquimod; topical

0.8

9.9

588

5298

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

0.9

9.9

4432

33224

I67.9

ICD-10 Finland

Cerebrovascular disease, unspecified

1.7

9.9

195

801

K59.1

ICD-10 Finland

Functional diarrhoea

1.3

9.9

899

4890

C10AA05

ATC

atorvastatin; oral

1.1

9.9

9164

59294

I67.2

ICD-10 Finland

Cerebral atherosclerosis

2.0

9.9

107

364

R51.80

ICD-10 Finland

Headache

1.2

9.9

1859

10892

F01.32

ICD-10 Finland

Mixed cortical and subcortical vascular dementia other additional symptoms, mainly hallucinations

10.5

9.9

F0014, G309,

ICD-10 Finland

+∞

9.8

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

0.5

9.8

100

1317

S72.2

ICD-10 Finland

Subtrochanteric fracture

1.7

9.8

173

689

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

0.6

9.8

223

2378

CBB11

NOMESCO Finland

Resection of lax skin in upper eyelid

0.6

9.8

222

2368

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.1

9.8

5936

37606

R999, ,

ICD-10 Finland

3.2

9.8

R05

ICPC

Cough

0.9

9.8

3264

24906

Z49.1

ICD-10 Finland

Extracorporeal dialysis

0.4

9.7

979

L02BB04

ATC

enzalutamide; oral

0.5

9.7

998

6271A

ICD-9 Finland

Menopausal and postmenopausal disorders, Postmenopausal bleeding

1.6

9.7

204

852

SPA41

NOMESCO Finland

Precision impression for fixed dental prosthesis

0.4

9.7

722

S97

ICPC

Chronic ulcer skin

1.2

9.7

1319

7500

WX404

NOMESCO Finland

Intravenous generell anesthesy

0.9

9.7

2311

18050

P01

ICPC

Feeling anxious/nervous/tense

1.3

9.7

705

3728

Z10.0

ICD-10 Finland

Occupational health examination

0.5

9.7

1024

F0001, G301,

ICD-10 Finland

82.2

9.7

N03AX09

ATC

lamotrigine; oral

1.5

9.6

315

1457

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

1.8

9.6

155

602

127

Kela drug reimbursment

Transplant complication

0.3

9.6

667

8140/3-C25.9

ICD-O-3

Adenocarcinoma, NOS, of pancreas, NOS

0.3

9.6

516

R1430, ,

SPAT

1.6

9.6

206

866

N05CD08

ATC

midazolam; nasal, systemic

1.4

9.6

403

1957

4148X

ICD-9 Finland

Other forms of chronic ischaemic heart disease, Other specified forms of chronic ischaemic heart disease[MORBUS CORDIS ISCHAEMICUS ALIA,MÄÄRITTELEMÄT]

0.4

9.6

827

S06.2

ICD-10 Finland

Diffuse brain injury

1.8

9.5

133

494

NFB10

NOMESCO Finland

Primary partial prosthetic replacement of hip joint not using cement, other or unspecified

2.3

9.5

233

E66.00

ICD-10 Finland

Metabolic syndrome

0.7

9.5

401

3804

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

1.7

9.5

178

722

WX722

NOMESCO Finland

PEEP

0.7

9.5

441

4117

R1100, ,

SPAT

1.6

9.5

203

853

S51.0

ICD-10 Finland

Open wound of elbow

1.6

9.5

210

890

P71

ICPC

Organic psychosis other

5.7

9.5

Z49.0

ICD-10 Finland

Preparatory care for dialysis

0.4

9.4

702

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

0.5

9.4

1013

R03BB01

ATC

ipratropium bromide; inhalant

0.8

9.4

560

5041

L57.0

ICD-10 Finland

Actinic keratosis

0.9

9.4

2061

16199

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

0.8

9.4

741

6431

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

1.7

9.4

178

725

S82.0

ICD-10 Finland

Fracture of patella

1.5

9.3

259

1158

F01.14

ICD-10 Finland

Multi-infarct dementia's other mixed symptoms of mixed type

5.3

9.3

F30.1

ICD-10 Finland

Mania without psychotic symptoms

4.5

9.3

M03BX02

ATC

tizanidine; oral

0.9

9.3

8057

58429

F06.2

ICD-10 Finland

Organic delusional [schizophrenia-like] disorder

3.4

9.3

S16

ICPC

Bruise/contusion

1.3

9.3

562

2897

G04BD04

ATC

oxybutynin; oral, transdermal

1.2

9.3

1040

5798

N95

ICD-10 Finland

Menopausal and other perimenopausal disorders

0.5

9.2

986

R2130, ,

SPAT

1.6

9.2

194

812

SPAT1243

SPAT

Psychiatric/psychological examination

1.8

9.2

133

500

ZXA00

NOMESCO Finland

Right side

1.1

9.2

5109

32195

ZYY01

NOMESCO Finland

Contact between professionals

3.4

9.2

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

0.8

9.2

663

5818

SGA01

NOMESCO Finland

Emergency treatment

0.8

9.1

1010

8440

R60.0

ICD-10 Finland

Localized oedema

1.1

9.1

2563

15491

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

0.6

9.1

129

1541

A02BD03

ATC

lansoprazole, amoxicillin and metronidazole; systemic

1.2

9.1

1260

7178

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

2.4

9.1

182

SPAT1232

SPAT

Communication with help of interpreter or assistant

2.8

9.1

114

C45.0

ICD-10 Finland

Mesothelioma of pleura

0.2

9.1

282

N31.8

ICD-10 Finland

Other neuromuscular dysfunction of bladder

2.1

9.1

274

A49

ICPC

General and Unspecified, Other preventive procedure

1.9

9.0

120

439

T11

ICPC

Dehydration

3.1

9.0

I95.2

ICD-10 Finland

Hypotension due to drugs

1.7

9.0

156

619

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.2

9.0

1818

10713

AEA50

NOMESCO Finland

Adjustment of implanted neurostimulator

3.0

9.0

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

0.8

9.0

667

5831

S30.1

ICD-10 Finland

Contusion of abdominal wall

1.7

9.0

179

739

F0003, G300,

ICD-10 Finland

+∞

8.9

F0023, G301,

ICD-10 Finland

+∞

8.9

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

0.5

8.9

1205

S32.4

ICD-10 Finland

Fracture of acetabulum

1.8

8.9

138

530

C10AA03

ATC

pravastatin; oral

1.2

8.9

1505

8735

K88

ICPC

Postural hypotension

1.6

8.9

193

814

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

0.5

8.9

944

Z01.2

ICD-10 Finland

Dental examination

0.9

8.9

5576

41091

L08

ICPC

Shoulder symptom/complaint

0.9

8.9

3041

23179

UJF32, ,

SPAT

0.7

8.8

243

2488

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

1.5

8.8

312

1467

M54.4

ICD-10 Finland

Lumbago with sciatica

0.9

8.8

1908

15015

A86

ICD-10 Finland

Unspecified viral encephalitis

2.2

8.8

224

DFF30

NOMESCO Finland

Loudness discomfort Level (LDL)

1.3

8.8

576

3004

F02.89

ICD-10 Finland

Dementia in another specified disease that is classified elsewhere without information of additional symptoms

5.3

8.8

ZX080

NOMESCO Finland

Image guided radiotherapy

0.6

8.8

126

1499

M02AA10

ATC

ketoprofen; topical

1.1

8.7

2663

16182

G91.1

ICD-10 Finland

Obstructive hydrocephalus

2.4

8.7

169

S01EX03, ,

ATC

1.4

8.7

454

2287

M70.6

ICD-10 Finland

Trochanteric bursitis

0.9

8.7

1737

13756

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

0.5

8.7

1067

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

0.4

8.7

624

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.2

8.7

1021

5721

SPAT1165

SPAT

Peritoneal dialysis

2.8

8.7

117

SAA01

NOMESCO Finland

Simple examination of mouth

1.1

8.7

10653

69652

HA1AE, ,

SPAT

0.5

8.7

908

ZXA05

NOMESCO Finland

Left side

1.1

8.7

4779

30088

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

2.2

8.7

230

Z97.4

ICD-10 Finland

Presence of external hearing-aid

1.2

8.6

1155

6559

R5120

NOMESCO Finland

Preparation of an aid

1.3

8.6

552

2869

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

0.4

8.6

742

7151F

ICD-9 Finland

Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, POLVI]

1.3

8.6

527

2721

TDA90, ,

SPAT

0.8

8.6

897

7542

C34.92

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma

0.2

8.6

271

ND1BA

NOMESCO Finland

Wrist extensive X-ray examination

1.4

8.6

335

1605

NA3BG, ,

SPAT

0.6

8.6

141

1620

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

0.8

8.6

530

4745

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

0.3

8.6

599

F07.8

ICD-10 Finland

Other organic personality and behavioural disorders due to brain disease, damage and dysfunction

4.5

8.6

R2110, ,

SPAT

4.5

8.6

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

0.5

8.6

1015

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

0.6

8.6

109

1339

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

1.3

8.5

652

3472

C07AB02

ATC

metoprolol; systemic

1.1

8.5

4757

29964

JAH01

NOMESCO Finland

Laparoscopy

0.7

8.5

265

2646

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

0.4

8.4

735

Z00.8

ICD-10 Finland

Other general examinations

1.2

8.4

1150

6543

R03AK08

ATC

formoterol and beclometasone; inhalant

0.7

8.4

336

3213

TQW40

NOMESCO Finland

Remowal of suture of skin

0.8

8.4

676

5853

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

0.8

8.4

515

4617

S29.9

ICD-10 Finland

Unspecified injury of thorax

2.0

8.4

348

X09

ICD-10 Finland

Exposure to unspecified smoke, fire and flames

3.2

8.4

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

0.3

8.4

551

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

0.4

8.4

743

Z50

ICD-10 Finland

Care involving use of rehabilitation procedures

3.8

8.4

NF3BA

NOMESCO Finland

Femur extensive X-ray examination

2.3

8.4

198

8306

FHL

Hysterectomy (related to abortion 8516, prolapse correction 8436)

0.7

8.4

299

2914

D25.1

ICD-10 Finland

Intramural leiomyoma of uterus

0.7

8.4

275

2719

IGY99

NOMESCO Finland

Other psychiatric treatment contact

1.9

8.3

100

354

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

1.5

8.3

244

1105

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

0.5

8.3

856

ZYY79

NOMESCO Finland

Other indirect service without contact with patient

4.6

8.3

R03BA08

ATC

ciclesonide; inhalant

0.8

8.3

752

6421

163

Kela drug reimbursment

Abiraterone and enzalutamide

0.5

8.3

1022

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

1.4

8.3

442

2236

T68

ICD-10 Finland

Hypothermia

2.1

8.3

266

R02

ICPC

Shortness of breath/dyspnoea

0.9

8.3

2078

16178

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

0.6

8.3

157

1740

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

0.4

8.3

619

G03FB05

ATC

norethisterone and estrogen; systemic

0.8

8.3

1175

9579

S72.8

ICD-10 Finland

Fractures of other parts of femur

2.2

8.3

239

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

0.9

8.2

6670

48606

F0282, G318,

ICD-10 Finland

27.4

8.2

R03DA04

ATC

theophylline; systemic, rectal

0.8

8.2

803

6797

XA400

NOMESCO Finland

EEG

2.1

8.2

276

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

1.4

8.2

446

2263

SCA02

NOMESCO Finland

Preventive oral health care

1.2

8.2

1080

6124

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

0.8

8.2

579

5091

N07CA01

ATC

betahistine; oral

1.2

8.2

1314

7594

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

1.7

8.2

136

535

137

Kela drug reimbursment

Uraemia requiring dialysis

0.3

8.2

500

I49.3

ICD-10 Finland

Ventricular premature depolarization

0.8

8.1

810

6842

SPAT1293

SPAT

Other function in accordance with rehabilitation guidance nomenclature

2.0

8.1

310

I61.1

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, cortical

1.7

8.1

138

546

R40.0

ICD-10 Finland

Somnolence

2.5

8.1

146

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

1.8

8.1

116

436

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

0.2

8.1

421

F0289, G318,

ICD-10 Finland

37.7

8.1

N02CD05

ATC

eptinezumab; parenteral

37.7

8.1

F0020, G309,

ICD-10 Finland

+∞

8.1

F0010, G308,

ICD-10 Finland

+∞

8.1

R21

ICPC

Throat symptom/complaint

0.9

8.0

1544

12265

G03FA14

ATC

dydrogesterone and estrogen; systemic

0.7

8.0

288

2803

L04AX03

ATC

methotrexate; systemic

0.8

8.0

910

7582

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.2

8.0

1883

11230

N05AN01

ATC

lithium; oral

1.6

8.0

188

810

TPH07

NOMESCO Finland

Cathetrisation of artery

0.9

8.0

1697

13377

N03AX18

ATC

lacosamide; systemic

2.0

8.0

293

Z93.5

ICD-10 Finland

Cystostomy status

2.3

8.0

198

XF610, ,

SPAT

2.5

8.0

147

114

Kela drug reimbursment

Glaucoma

1.2

8.0

2061

12379

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

0.4

8.0

775

G03FB08

ATC

dydrogesterone and estrogen; systemic

0.7

7.9

252

2507

NFJ52

NOMESCO Finland

Internal fixation of fracture of upper femur with screws and sideplate

1.7

7.9

158

653

A06AC51

ATC

ispaghula, combinations; oral

1.3

7.9

733

4000

6000A

ICD-9 Finland

Hyperplasia of prostate[HYPERPLASIA PROSTATAE]

1.4

7.9

362

1787

I62.0

ICD-10 Finland

Nontraumatic subdural haemorrhage

1.7

7.9

149

607

E66

ICD-10 Finland

Obesity

0.6

7.9

185

1955

R12

ICD-10 Finland

Heartburn

0.8

7.9

781

6601

Z94.0

ICD-10 Finland

Kidney transplant status

0.3

7.9

502

C34.36

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung microcellular carcinoma

0.1

7.9

196

M01AX05

ATC

glucosamine; oral

1.1

7.9

4209

26441

S01.51

ICD-10 Finland

Open wound on lip

1.5

7.9

211

938

NB1BG, ,

SPAT

0.4

7.8

583

SPAT1107

SPAT

Extensive external surface anaesthesia of skin with cream or gel

2.2

7.8

209

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

0.9

7.8

2421

18577

YX9AW, ,

NOMESCO Finland

0.2

7.8

365

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.1

7.8

2961

18248

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.2

7.7

1140

6537

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

0.7

7.7

201

2077

SPAT1312

SPAT

General health counselling

1.1

7.7

5135

32615

K86

ICPC

Hypertension uncomplicated

0.9

7.7

2308

17754

SGA02

NOMESCO Finland

Opening and preparing the root canals

0.8

7.7

1108

9020

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

0.4

7.7

567

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

0.6

7.7

1174

H40.9

ICD-10 Finland

Glaucoma, unspecified

1.4

7.7

365

1815

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

0.2

7.7

222

IGY02

NOMESCO Finland

Psychiatric monitoring contact

1.6

7.7

181

782

S02.20

ICD-10 Finland

Fracture of nasal bones, closed

1.6

7.6

191

836

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

0.3

7.6

493

JAL30

NOMESCO Finland

Omentectomy

0.4

7.6

665

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

0.6

7.6

134

1510

K05.30

ICD-10 Finland

Periodontitis complex

0.9

7.6

1799

14068

S18

ICPC

Laceration/cut

0.9

7.6

8324

59937

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

1.3

7.6

494

2576

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.1

7.6

4108

25821

N05CF01

ATC

zopiclone; oral

1.1

7.6

6394

41058

191

Kela drug reimbursment

Erlotinib

0.1

7.5

190

G04BE04

ATC

yohimbine; oral

1.6

7.5

163

689

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

0.5

7.5

1123

SAE02, ,

NOMESCO Finland

0.4

7.5

571

R39.1

ICD-10 Finland

Other difficulties with micturition

1.3

7.5

538

2844

SAE03, ,

NOMESCO Finland

0.1

7.5

204

F02.09

ICD-10 Finland

Dementia in Pick's disease without information on additional symptoms

9.1

7.5

I95.0

ICD-10 Finland

Idiopathic hypotension

2.6

7.5

123

M05BA02

ATC

clodronic acid; systemic

0.3

7.5

423

UJF30

NOMESCO Finland

Ileoscopy through colon

0.8

7.5

1193

9623

F91.9

ICD-10 Finland

Conduct disorder, unspecified

12.0

7.5

322

Kela drug reimbursment

Sunitinib

0.0

7.5

153

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

0.3

7.4

454

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

1.2

7.4

753

4155

159

Kela drug reimbursment

Pazopanib

0.0

7.4

154

L02BA03

ATC

fulvestrant; parenteral

0.3

7.4

432

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

0.7

7.4

254

2490

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

0.4

7.4

676

S06.9

ICD-10 Finland

Intracranial injury, unspecified

1.9

7.4

345

B03XA01

ATC

erythropoietin; parenteral

0.5

7.4

752

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

0.6

7.4

101

1214

SAD02, ,

SPAT

7.3

7.4

R41.2

ICD-10 Finland

Retrograde amnesia

3.3

7.4

C16.0

ICD-10 Finland

Malignant neoplasm: Cardia

0.1

7.4

187

P19

ICPC

Drug abuse

2.6

7.4

112

ZYB04

NOMESCO Finland

Outreach service in patient’s home or everyday environment

2.6

7.4

112

P15

ICPC

Chronic alcohol abuse

1.5

7.4

223

1019

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

1.4

7.4

352

1752

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

0.4

7.4

664

SPA30

NOMESCO Finland

Grinding of a single crown and bridge pillar or a single post and crown

0.4

7.4

555

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

0.7

7.4

201

2055

L04AX01

ATC

azathioprine; systemic

0.7

7.4

272

2630

A10BJ02

ATC

liraglutide; parenteral

0.6

7.3

136

1513

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

1.7

7.3

145

599

SPAT1277

SPAT

Instruction concerning legal protection and patient’s rights

3.1

7.3

L12.0

ICD-10 Finland

Bullous pemphigoid

1.7

7.3

126

501

A10AD05

ATC

insulin aspart; parenteral

1.4

7.3

364

1824

JAL20

NOMESCO Finland

Excision or destruction of lesion of peritoneum

0.1

7.3

168

R44

ICPC

Respiratory, Preventive immunization/medic

1.4

7.3

284

1364

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

0.7

7.3

379

3472

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

0.7

7.3

379

3472

JN4CD

NOMESCO Finland

Very extensive body CT

0.7

7.3

399

3628

Z75.9

ICD-10 Finland

Unspecified problem related to medical facilities and other health care

2.2

7.3

180

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

0.6

7.3

1164

R10.1

ICD-10 Finland

Pain localized to upper abdomen

0.9

7.3

2131

16417

TKE00

NOMESCO Finland

Needle biopsy of prostate

1.2

7.3

866

4865

A13

ICPC

Concern/fear medical treatment

1.4

7.3

318

1560

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

0.6

7.2

1163

ZX090

NOMESCO Finland

Other technic of radiotherapy

0.7

7.2

230

2285

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

0.7

7.2

198

2024

P76

ICPC

Depressive disorder

1.3

7.2

448

2321

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.5

7.2

244

1140

ND2AA, ,

SPAT

0.6

7.2

117

1345

R01AD12

ATC

fluticasone furoate; nasal

0.9

7.2

2764

20950

K03.11

ICD-10 Finland

Abrasion dentifrice of teeth

0.6

7.2

160

1709

Z27

ICPC

Fear of a social problem

2.4

7.2

142

H02BX01

ATC

methylprednisolone, combinations; systemic

1.2

7.2

948

5378

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

0.7

7.2

217

2177

U70

ICPC

Pyelonephritis/pyelitis

1.5

7.2

213

969

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.1

7.2

3832

24058

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

0.8

7.2

642

5484

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

0.7

7.2

221

2208

I21.2

ICD-10 Finland

Acute transmural myocardial infarction of other sites

0.4

7.2

518

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.3

7.2

717

3951

SPAT1324

SPAT

Screening procedure

0.7

7.2

396

3596

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

0.5

7.2

808

E44.1

ICD-10 Finland

Mild protein-energy malnutrition

3.7

7.2

SAD01, ,

SPAT

3.7

7.2

F0012, G308,

ICD-10 Finland

+∞

7.2

F0029, G309,

ICD-10 Finland

+∞

7.2

F0009, G309,

ICD-10 Finland

+∞

7.2

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.2

7.1

1409

8291

C09CA06

ATC

candesartan; oral

0.9

7.1

3327

24939

XKC03

NOMESCO Finland

Water cystometry

1.3

7.1

478

2505

XW000

NOMESCO Finland

Bone marrow biopsy

0.8

7.1

464

4120

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

0.6

7.1

111

1288

E87.6

ICD-10 Finland

Hypokalaemia

1.3

7.1

584

3143

-30

ICPC

Medical examin/health eval complete

1.4

7.1

377

1908

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

0.5

7.1

1069

TFP34

NOMESCO Finland

Electrophysiological investigation

0.7

7.1

186

1916

DFF15

NOMESCO Finland

Speech audiometry

1.2

7.1

956

5439

SGA04

NOMESCO Finland

Opening and preparing the root canals, extremely complicated

0.8

7.1

573

4950

OAB50, ,

SPAT

1.2

7.1

1302

7618

F01.89

ICD-10 Finland

Other specified vascular dementia without information on additional symptoms

4.1

7.1

N06BA04

ATC

methylphenidate; oral

2.5

7.1

131

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

0.9

7.1

1483

11697

HAB40

NOMESCO Finland

Wedge excision of mammary gland

0.8

7.0

457

4058

K43.2

ICD-10 Finland

Incisional hernia without obstruction or gangrene

0.3

7.0

386

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1.3

7.0

647

3532

F01.31

ICD-10 Finland

Mixed cortical and subcortical vascular dementia other additional symptoms, mainly paranoidism

7.3

7.0

WZC15, ,

NOMESCO Finland

0.4

7.0

543

L01BC59

ATC

trifluridine, combinations; systemic

0.1

7.0

195

OAB72, ,

SPAT

0.3

7.0

418

R07.4

ICD-10 Finland

Chest pain, unspecified

1.1

7.0

5375

34343

SPAT1211

SPAT

Application of soft bandage

1.2

7.0

1471

8702

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

0.7

7.0

171

1786

4402A

ICD-9 Finland

Atherosclerosis, Of native arteries of the extremities

0.6

7.0

100

1185

F06.8

ICD-10 Finland

Other specified mental disorders due to brain damage and dysfunction and to physical disease

3.4

7.0

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

0.8

7.0

759

6345

S02.51

ICD-10 Finland

Fracture of tooth, open

0.8

7.0

782

6517

L02BA01

ATC

tamoxifen; oral

0.7

7.0

294

2779

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

0.7

7.0

213

2129

D01AE16

ATC

amorolfine; topical

1.1

7.0

1975

11942

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

0.5

7.0

981

J01

ICD-10 Finland

Acute sinusitis

0.7

6.9

265

2547

L01AX03

ATC

temozolomide; systemic

0.2

6.9

338

D10

ICPC

Vomiting

1.4

6.9

377

1917

N02CD07, ,

ATC

7.8

6.9

N05AL01

ATC

sulpiride; systemic

1.5

6.9

186

829

SPAT1062

SPAT

Lung clearance therapy

2.1

6.9

211

AA5NK

NOMESCO Finland

Tractography within white matter of central nervous system

18.8

6.9

N02CD02

ATC

galcanezumab; parenteral

6.5

6.9

K28

ICPC

Limited function/disability (K)

1.3

6.9

446

2326

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

1.2

6.9

764

4259

B01AC24

ATC

ticagrelor; oral

0.7

6.9

358

3279

A03FA02

ATC

cisapride; oral, rectal

1.2

6.9

1386

8168

Z59.8

ICD-10 Finland

Other problems related to housing and economic circumstances

3.4

6.9

ZX070

NOMESCO Finland

Intensity modified radiotherapy

0.6

6.9

135

1480

M03AX01

ATC

botulinum toxin; parenteral

2.1

6.9

198

S72.9

ICD-10 Finland

Fracture of femur, part unspecified

1.9

6.9

330

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

0.4

6.9

586

G40.89

ICD-10 Finland

Other epilepsy

2.2

6.8

194

J01FA15

ATC

telithromycin; oral

0.8

6.8

795

6602

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

1.6

6.8

178

788

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

1.7

6.8

120

481

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

0.8

6.8

559

4821

G21.0

ICD-10 Finland

Malignant neuroleptic syndrome

4.3

6.8

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

1.7

6.8

134

554

SPAT1058

SPAT

PEF monitoring instruction

0.8

6.8

947

7730

F0234, G20,

ICD-10 Finland

13.7

6.8

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

1.8

6.8

351

ZXC96

NOMESCO Finland

Robot assisted procedure

0.7

6.8

182

1865

Z49.2

ICD-10 Finland

Other dialysis

0.3

6.8

388

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

0.8

6.8

547

4725

H81

ICPC

Excessive ear wax

1.1

6.8

3669

23051

W17

ICD-10 Finland

Other fall from one level to another

1.3

6.7

520

2778

A10BH01

ATC

sitagliptin; oral

1.2

6.7

1768

10631

F22.8

ICD-10 Finland

Other persistent delusional disorders

3.1

6.7

P27

ICPC

Fear of mental disorder

1.9

6.7

332

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

0.8

6.7

497

4341

R30.1

ICD-10 Finland

Vesical tenesmus

1.4

6.7

334

1674

180

Kela drug reimbursment

Interferon alfa

0.2

6.7

260

N43

ICPC

Neurological, Other diagnostic procedure

1.9

6.7

284

K29

ICPC

Cardiovascular sympt/complt other

1.2

6.7

863

4887

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

0.7

6.7

221

2178

SPAT1109

SPAT

Analgesia with portable analgesic pump

1.7

6.7

112

443

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

0.9

6.7

2208

16885

N31.0

ICD-10 Finland

Uninhibited neuropathic bladder, not elsewhere classified

2.1

6.7

196

D39.10

ICD-10 Finland

Tumor of uncertain or unknown nature in the ovary without histology

0.6

6.7

107

1231

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.1

6.7

2284

13979

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

0.7

6.7

222

2184

N03AB02

ATC

phenytoin; systemic

1.5

6.7

180

804

I42.0

ICD-10 Finland

Dilated cardiomyopathy

0.7

6.6

252

2423

A01AB09

ATC

miconazole; local oral

1.2

6.6

1428

8464

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.8

6.6

924

7537

K64.0

ICD-10 Finland

First degree haemorrhoids

0.6

6.6

127

1397

1CD01, ,

NOMESCO Finland

0.1

6.6

157

N07BA03

ATC

varenicline; oral

0.7

6.6

166

1722

N50

ICPC

Neurological, Medication/prescr/renewal

4.4

6.6

F01.84

ICD-10 Finland

Other specified vascular dementia other mixed symptoms of mixed type

4.2

6.6

V613A

ICD-9 Finland

Other family circumstances, Problems with aged parents or in-laws

7.9

6.6

ZXD35

NOMESCO Finland

Usual procedure

1.3

6.6

465

2458

PJA10

NOMESCO Finland

Exploration of lymph nodes

0.5

6.5

855

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

0.5

6.5

855

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

0.7

6.5

223

2184

ZX112

NOMESCO Finland

Subcutaneous

0.7

6.5

164

1703

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

0.6

6.5

1059

S52.0

ICD-10 Finland

Fracture of upper end of ulna

1.5

6.5

224

1052

3051, ,

Kela drug reimbursment

0.1

6.5

186

JLC30

NOMESCO Finland

Pancreatoduodenectomy

0.3

6.5

422

A23

ICPC

Risk factor NOS

1.2

6.5

1046

6050

B05DA

ATC

Isotonic solutions

0.3

6.5

390

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

0.5

6.5

725

I95

ICD-10 Finland

Hypotension

1.8

6.5

346

S01.40

ICD-10 Finland

Open wound on the cheek

1.8

6.5

361

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.1

6.5

5023

32092

F01.33

ICD-10 Finland

Mixed cortical and subcortical vascular dementia other additional symptoms, mainly depression

5.9

6.5

R03BB04

ATC

tiotropium bromide; inhalant

0.9

6.5

1689

13116

H82

ICPC

Vertiginous syndrome

1.4

6.5

284

1396

C09DX04

ATC

valsartan and sacubitril; oral

0.5

6.4

740

F02.04

ICD-10 Finland

Dementia in Pick's disease other additional symptoms of mixed type

30.8

6.4

L29

ICPC

Musculoskeletal sympt/complt other

1.2

6.4

1402

8319

DFF00, ,

SPAT

0.6

6.4

106

1209

C34.00

ICD-10 Finland

Malignant tumor of the main bronchus without histology

0.3

6.4

439

45499

ICD-8 Finland

Varicose veins of lower extremities, Other and unspecified, without ulcer

1.2

6.4

1399

8301

XX9LA

NOMESCO Finland

Complementary kinetic X-ray examination without contrast

1.7

6.4

118

480

T83

ICPC

Overweight

0.5

6.4

812

GBB00

NOMESCO Finland

Tracheostomy

0.5

6.4

866

D11

ICPC

Diarrhoea

1.2

6.4

1349

7984

N05AX16

ATC

brexpiprazole; oral

3.4

6.4

S01ED51

ATC

timolol, combinations; ophthalmic

1.1

6.4

1676

10082

7451

FHL

Transurethral adenoma removal

1.4

6.4

250

1205

A10BX01

ATC

guar gum; oral

1.2

6.4

742

4162

1412

FHL

Laparoscopy and sterilization

0.8

6.4

487

4232

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

0.6

6.4

1094

WX111

NOMESCO Finland

Local infiltration anesthesia

0.8

6.4

375

3370

OAB71, ,

SPAT

0.4

6.4

596

N06BA07

ATC

modafinil; oral

3.9

6.4

S09.8

ICD-10 Finland

Other specified injuries of head

1.7

6.4

103

404

K02.1

ICD-10 Finland

Caries of dentine

1.1

6.4

8082

52686

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

0.6

6.3

1050

8070/3-C15.9

ICD-O-3

Squamous cell carcinoma, NOS, of esophagus, NOS

0.1

6.3

184

E66.8

ICD-10 Finland

Other obesity

0.7

6.3

216

2115

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

2.2

6.3

160

S79.9

ICD-10 Finland

Unspecified injury of hip and thigh

1.6

6.3

143

613

SPAT1154

SPAT

Insertion or removal of subcutaneous medicine capsule

2.3

6.3

147

D06

ICPC

Abdominal pain localized other

0.8

6.3

888

7241

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

0.8

6.3

612

5178

-1, ,

NOMESCO Finland

1.1

6.3

4056

25689

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

1.3

6.3

505

2713

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

0.7

6.3

151

1582

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

0.2

6.3

250

ZY000

NOMESCO Finland

Hospital inpatient

1.8

6.3

325

LCD04

NOMESCO Finland

Laparoscopic hysterectomy

0.7

6.3

175

1779

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

0.3

6.3

361

GX1B5, ,

SPAT

0.4

6.3

545

5509B

ICD-9 Finland

Inguinal hernia, without mention of obstruction or gangrene[HERNIA INGUINALIS SINE GANGR/OBSTR,LATERALIS (SCROT]

1.3

6.3

373

1924

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.1

6.3

4700

29979

OAA64, ,

SPAT

0.2

6.3

208

Q90

ICD-10 Finland

Down syndrome

+∞

6.3

F0011, G309,

ICD-10 Finland

+∞

6.3

F028, G318,

ICD-10 Finland

+∞

6.3

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

1.4

6.3

304

1520

H13

ICPC

Plugged feeling ear

1.1

6.3

3962

25075

H02AB07

ATC

prednisone; oral

0.9

6.3

1929

14816

F0029, G301,

ICD-10 Finland

54.8

6.3

Q90.0

ICD-10 Finland

Trisomy 21, meiotic nondisjunction

54.8

6.3

K31

ICPC

Cardiovascular, Medical examin/health eval partial

1.7

6.3

117

478

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

0.3

6.2

370

TFP46

NOMESCO Finland

Ablation treatment of atrial fibrillation

0.5

6.2

832

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

0.5

6.2

704

A12AA12

ATC

[U] calcium acetate

0.1

6.2

164

3018

Kela drug reimbursment

The combination of trifluridine and tipiracil

0.2

6.2

178

1506

Kela drug reimbursment

The combination of trifluridine and tipiracil

0.2

6.2

179

H02.3

ICD-10 Finland

Blepharochalasis

0.8

6.2

823

6745

CHD00

NOMESCO Finland

Laser trabeculoplasty

1.4

6.2

234

1120

L02BX03

ATC

abiraterone; oral

0.5

6.2

767

N30

ICD-10 Finland

Cystitis

1.2

6.2

1042

6053

T19.1

ICD-10 Finland

Foreign body in bladder

3.7

6.2

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

0.9

6.2

4581

33599

R03.1

ICD-10 Finland

Nonspecific low blood-pressure reading

2.1

6.2

198

OAB27, ,

SPAT

0.0

6.2

107

A58

ICPC

General and Unspecified, Therapeutic counselling/listening

2.9

6.2

L84

ICD-10 Finland

Corns and callosities

1.3

6.2

522

2825

B02

ICD-10 Finland

Zoster [herpes zoster]

0.8

6.2

424

3732

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

1.8

6.1

383

D01BA02

ATC

terbinafine; oral

1.1

6.1

4187

26591

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

0.7

6.1

247

2349

P01AB01

ATC

metronidazole; oral, rectal

0.9

6.1

5396

39289

NFB41, ,

NOMESCO Finland

0.3

6.1

366

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

1.6

6.1

125

523

L01XE03

ATC

[U] erlotinib

0.1

6.1

147

K03.19

ICD-10 Finland

Abrasion of the teeth UNS

0.6

6.1

959

C01BD01

ATC

amiodarone; systemic

0.8

6.1

346

3124

QX3HE, ,

SPAT

0.4

6.1

448

J01CA04

ATC

amoxicillin; systemic

1.1

6.1

14202

94605

WX780

NOMESCO Finland

Remote monitoring CPAP

0.7

6.1

266

2496

G03DB01

ATC

dydrogesterone; oral

0.8

6.1

597

5041

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

0.7

6.1

166

1692

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

0.8

6.1

339

3068

A80

ICPC

Trauma/injury NOS

1.6

6.1

143

620

V03AF03

ATC

calcium folinate; systemic

0.1

6.1

160

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

0.8

6.1

335

3036

Z74.0

ICD-10 Finland

Need for assistance due to reduced mobility

3.1

6.0

KE1DG

NOMESCO Finland

Very extensive MRI of prostate

0.4

6.0

574

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

0.3

6.0

363

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

0.4

6.0

564

I67.8

ICD-10 Finland

Other specified cerebrovascular diseases

1.9

6.0

247

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

0.7

6.0

147

1533

XX1AD

NOMESCO Finland

Other CT-examination

0.4

6.0

495

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3015377) Calcium [Moles/volume] in Serum or Plasma

10131

49587

1.74

318.16

2.6

3.6

2.35

mmol/l

0.18

9039

44078

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

7174

30629

1.89

307.65

2.7

3.2

2.46

2.47

mmol/l

22.96

6444

27164

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

1273

512

18.00

307.65

1.0

51.00

32.15

ng/l

26.06

939

312

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

1259

517

17.62

307.65

1.0

385.17

306.71

ng/l

1.69

940

326

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1331

2501

3.81

307.65

1.2

1.3

485.13

605.56

mg/l

7.78

1236

2407

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

1273

509

18.10

307.65

1.0

596.96

832.50

ng/l

21.05

928

303

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1202

2180

3.93

307.65

1.2

1.3

3.84

mmol/l

0.03

1144

2058

(3021960) Folate [Moles/volume] in Serum or Plasma

11159

44901

2.42

307.65

1.9

1.8

20.28

20.24

nmol/l

0.10

9507

37152

(3019309) Folate [Moles/volume] in Red Blood Cells

8570

28654

2.71

307.65

1.9

1.8

1165.82

1147.64

nmol/l

0.94

6437

20993

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

7265

30605

1.93

307.65

1.9

1.8

5395268.86

30607193.62

pmol/l

8.33

5876

24145

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1189

2148

3.95

307.65

1.3

1.4

421.57

2488.84

e6/l

1.29

927

1724

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

13614

65876

2.08

307.65

2.6

2.3

93.20

94.09

pmol/l

1.25

7500

34386

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1180

2125

3.96

307.65

1.2

1.4

11.33

38.06

e6/l

2.19

867

1601

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

14010

76234

1.71

285.62

5.7

7.6

1.22

1.21

mmol/l

53.95

11828

65064

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

11147

57842

1.65

262.00

2.3

2.4

78.05

81.22

nmol/l

23.54

9563

50223

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

12592

68499

1.60

231.90

5.1

6.9

1.22

1.21

mmol/l

30.46

11301

62721

(3024561) Albumin [Mass/volume] in Serum or Plasma

12292

66761

1.59

224.53

3.9

5.1

34.86

34.32

g/l

21.40

11123

62028

(3031040) Bacteria [#/volume] in Urine by Automated count

15531

89464

1.64

219.55

6.4

5.6

2809.79

1617.32

e6/l

1.76

373

1370

(3026008) Bacteria identified in Urine by Culture

9614

49655

1.58

213.78

4.0

3.7

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

6029

28136

1.64

200.87

2.0

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

680

1255

3.79

192.69

3.7

4.2

325.83

332.06

umol/l

0.47

573

1071

(3018418) pH of Serum or Plasma

8804

45988

1.52

173.99

3.2

4.5

7.40

3.79

6545

33325

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

4598

21114

1.62

156.82

2.0

1.9

—

(3023410) Appearance of Cerebral spinal fluid

514

897

3.99

156.77

1.2

1.4

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

4235

19553

1.60

138.94

2.0

1.9

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

14907

89019

1.45

130.88

4.2

4.5

15.29

15.22

pmol/l

2.64

13170

79256

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

17354

107175

1.51

123.95

5.7

2.02

2.09

mu/l

6.76

15651

96212

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

10203

57307

1.41

122.30

4.8

4.7

52.83

89.90

ng/l

2.90

8477

46815

(3023368) Bacteria identified in Blood by Culture

8474

46160

1.42

120.33

4.0

4.6

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

8464

46527

1.40

111.34

2.4

2.2

257.48

212.22

u/l

4.44

7964

43558

(3037467) Urinalysis macro (dipstick) panel - Urine

14815

89861

1.39

103.57

5.6

5.4

2.60

95.31

0.49

142

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

5498

48496

0.70

102.33

1.8

2.0

1.21

1.27

mmol/l

5.98

4479

38769

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

18280

115543

1.49

97.43

21.2

21.4

29.87

28.38

mg/l

6.51

16118

99272

(3019150) Specific gravity of Urine by Refractometry

5720

29925

1.42

96.70

5.3

4.9

1.02

1.12

kg/l

0.81

3950

20595

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

7587

41658

1.38

96.31

2.4

2.5

2.87

3.04

mg/l

7.20

6334

35615

(3016018) Differential panel - Cerebral spinal fluid

490

1148

2.96

96.20

1.1

1.3

—

(40768804) Tissue Pathology biopsy report

6117

52352

0.72

91.57

2.2

2.4

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

13574

82367

1.33

83.78

4.8

5.4

7.00

6.88

mmol/l

6.33

13038

78761

(3035350) Ketones [Presence] in Urine by Test strip

11660

69536

1.31

78.95

4.9

4.6

4.44

3.54

estimate

0.21

2478

15784

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2370

10834

1.56

76.73

1.8

—

(3012516) Albumin [Mass/volume] in Urine

6172

51476

0.75

71.76

3.1

3.5

54.92

51.23

mg/l

0.43

4035

33119

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

237

417

3.92

71.60

1.2

45.22

58.34

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

8671

50086

1.30

71.40

5.1

4.8

0.62

0.82

estimate

0.20

1933

12347

(3009261) Glucose [Presence] in Urine by Test strip

11654

70119

1.29

69.72

4.9

4.6

0.58

0.38

estimate

0.17

2306

14794

(3019550) Sodium [Moles/volume] in Serum or Plasma

18719

120500

1.42

69.17

26.7

26.5

139.72

139.48

mmol/l

25.26

18310

118055

(3023103) Potassium [Moles/volume] in Serum or Plasma

18725

120584

1.42

68.54

26.8

4.00

4.01

mmol/l

5.82

18297

117993

(3021601) Nitrite [Presence] in Urine by Test strip

11428

68675

1.29

68.43

4.8

4.6

0.00

estimate

0.03

2349

15227

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

340

797

2.95

66.75

2.2

2.3

—

(3009508) Creatinine [Moles/volume] in Urine

6267

51803

0.76

66.66

3.1

3.5

6.93

6.82

mmol/l

1.38

5079

42421

(4035726) Immunohistochemistry procedure

1221

13530

0.60

64.19

1.3

1.4

—

(3015736) pH of Urine

9417

55578

1.28

62.83

4.2

4.0

6.33

6.31

0.53

5044

28966

(3020564) Creatinine [Moles/volume] in Serum or Plasma

18755

121315

1.39

60.52

28.4

29.3

84.64

85.78

umol/l

3.97

18393

119505

(3010813) Leukocytes [#/volume] in Blood

18774

121589

1.38

58.51

31.8

32.6

7.09

7.00

e9/l

3.75

18172

117757

(3007461) Platelets [#/volume] in Blood

18766

121567

1.38

57.93

31.8

32.6

235.94

239.37

e9/l

9.77

18232

118313

(3035941) MCH [Entitic mass]

18766

121572

1.38

57.85

31.7

32.4

30.46

30.45

0.59

18405

119725

(3026361) Erythrocytes [#/volume] in Blood

18766

121577

1.38

57.77

31.8

32.5

4.27

4.34

e12/l

77.78

18156

117696

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

18765

121575

1.38

57.69

32.2

33.1

38.55

39.25

30.75

18397

119675

(3024731) MCV [Entitic mean volume] in Red Blood Cells

18765

121575

1.38

57.69

31.7

32.5

92.09

91.99

2.15

18407

119731

(3000963) Hemoglobin [Mass/volume] in Blood

18766

121586

1.38

57.64

32.0

32.8

128.81

131.07

g/l

79.42

18403

119793

(3020682) Albumin/Creatinine [Ratio] in Urine

6506

52678

0.78

55.44

3.7

4.3

9.22

9.50

mg/mmol

0.17

4093

32718

(3032080) INR in Blood by Coagulation assay

12020

73792

1.25

53.94

19.9

20.4

1.39

1.37

inr

3.88

10409

62286

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1976

19009

0.68

53.00

1.2

1.3

16.72

14.93

u/ml

0.38

609

6292

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

166

297

3.85

49.20

1.2

1.3

31.00

24.96

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

15761

100352

1.26

48.23

6.3

9.0

80.45

83.41

u/l

7.28

14609

94770

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

14681

92738

1.25

47.93

4.3

4.9

14.50

15.40

mm/h

8.79

13266

85210

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

152

261

4.01

47.56

1.8

2.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

152

262

3.99

47.33

1.8

2.0

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2184

20186

0.71

45.91

1.2

1.3

46.79

42.04

iu/ml

0.57

664

6062

(3029937) Albumin [Presence] in Urine by Test strip

6900

40393

1.25

44.28

5.0

4.7

0.00

estimate

2.39

2043

13624

(3037522) Nuclear Ab [Titer] in Serum

1630

15666

0.69

42.64

1.3

522.16

516.85

titre

0.04

370

3752

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1102

11374

0.65

41.41

1.3

1.4

—

(3006270) Folate [Moles/volume] in Blood

355

1114

2.20

38.70

1.3

1.2

319.43

305.95

nmol/l

0.53

286

826

(3019225) pH of Specimen

2896

15497

1.32

37.22

3.9

4.6

7.36

7.37

0.62

1937

10939

(3003694) ABO and Rh group [Type] in Blood

3867

31958

0.79

34.86

1.2

1.3

—

(3002256) Pathology report gross observation

2165

19282

0.74

34.81

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1102

10982

0.67

34.53

1.4

1.5

—

(1761868) Lipid panel - Serum or Plasma

3805

31358

0.80

33.17

3.6

4.0

—

(3041096) Erythrocytes [Presence] in Urine by Automated

5780

34085

1.22

32.11

4.4

4.2

0.54

0.36

estimate

0.32

1807

11858

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1140

5366

1.48

31.14

1.2

1.3

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1546

7757

1.39

29.82

1.5

1.6

1.63

1.64

0.10

1272

6249

(3028026) IgM [Mass/volume] in Serum or Plasma

746

7789

0.64

29.24

1.9

2.0

1.82

1.40

g/l

1.59

633

7003

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

167

2721

0.42

28.84

1.6

1.9

3.02

3.24

mmol/l

1.57

124

1998

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1143

10909

0.70

28.04

1.4

1.5

—

(3014271) Vancomycin [Susceptibility]

302

1013

2.05

27.95

3.0

3.1

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

13616

87229

1.18

27.91

29.1

28.9

330.32

330.50

g/l

1.48

13465

86633

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

295

3873

0.51

27.85

1.7

2.1

3.02

3.26

ratio

3.74

247

3154

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2160

18715

0.77

27.83

3.1

4.2

12.02

27.05

ug/l

3.33

1775

15770

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

531

5868

0.61

26.74

2.4

4.3

105.95

92.59

u/ml

0.18

504

5651

(3019832) Treponema pallidum Ab [Presence] in Serum

645

2775

1.61

26.45

1.2

1.4

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2340

12701

1.29

26.44

3.0

4.2

1.23

mmol/l

2.89

1896

10907

(3017143) Hepatitis C virus Ab [Presence] in Serum

996

9626

0.69

26.19

1.4

1.5

—

(3017181) Myelocytes/Leukocytes in Blood

1495

13521

0.74

26.11

3.5

4.1

1.01

0.96

0.22

416

4538

(3002179) Metamyelocytes/Leukocytes in Blood

1403

12804

0.73

26.02

3.3

4.0

0.75

0.71

0.16

383

4307

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

5136

30529

1.20

25.02

4.5

218.07

450.78

ng/l

6.69

4630

26979

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

264

881

2.06

24.83

1.2

2.13

2.34

mmol/l

1.23

245

808

(3021440) Promyelocytes/Leukocytes in Blood

1428

12904

0.74

24.73

3.5

4.1

0.12

0.11

0.14

354

3956

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

251

823

2.10

24.71

1.1

—

(3026493) Urate [Moles/volume] in Serum or Plasma

4690

36936

0.83

24.59

2.5

3.1

352.22

362.02

umol/l

7.16

3814

31354

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

18123

119574

1.21

23.59

11.5

14.2

22.12

24.10

u/l

14.58

17219

114994

(3025159) Blasts/Leukocytes in Blood

1430

12826

0.75

23.46

3.5

4.3

0.41

0.33

0.12

335

3710

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1186

10886

0.73

22.71

1.3

—

(3022145) Colonoscopy Study observation

1807

15604

0.77

22.28

1.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

632

6436

0.66

21.87

1.2

1.3

—

(4024509) Urine culture

1366

7061

1.35

21.73

2.1

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1055

9778

0.73

21.47

2.7

2.9

10.70

g/l

0.00

919

8972

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

325

1227

1.82

21.44

1.3

1.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1193

6071

1.36

20.99

1.8

1.9

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

670

6684

0.68

20.86

1.4

1.5

41.49

17.15

iu/ml

0.93

141

(3005322) IgE [Units/volume] in Serum or Plasma

606

6150

0.67

20.61

1.3

252.79

255.52

u/ml

0.03

541

5626

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

197

2665

0.50

20.51

3.3

4.1

314.58

1511.15

iu/ml

1.12

397

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

2608

14791

1.23

19.98

2.4

2.5

5.76

6.57

ug/l

1.57

1998

12833

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1171

5989

1.36

19.96

1.9

2.2

795.90

565.75

ug/l

0.63

1101

5711

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1260

6531

1.34

19.67

1.9

2.0

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

340

3882

0.59

19.60

2.0

3.2

200.44

980.16

u/ml

2.98

297

3520

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

421

4563

0.62

19.52

1.6

1.4

21.74

15.95

iu/ml

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

340

3872

0.59

19.41

2.0

2.1

3.63

3.65

g/l

0.13

322

3691

(3011397) Hemoglobin [Presence] in Urine by Test strip

5471

33271

1.17

19.40

4.7

4.3

0.29

0.26

0.08

426

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

371

4134

0.61

19.37

1.4

1.5

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1899

16032

0.79

19.21

4.2

6.3

10.94

11.71

mmol/l

4.30

1747

15155

(3021589) Normoblasts [#/volume] in Blood

7586

56707

0.87

19.07

12.2

13.5

0.00

e9/l

1.02

6199

45774

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

3000

17376

1.21

18.59

9.2

8.5

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1922

10623

1.26

18.47

5.3

6.7

24.39

24.55

mmol/l

1.02

1849

10185

(3002582) Erythrocytes [#/volume] in Urine

8009

50234

1.14

18.24

3.8

102.65

104.36

e6/l

0.03

6263

39087

(3023420) DNA double strand Ab [Units/volume] in Serum

474

4920

0.65

18.03

1.7

1.6

8.22

8.08

iu/ml

0.03

125

1149

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

652

6345

0.69

17.73

2.3

3.3

226.91

2398.84

u/ml

3.24

528

5461

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

1361

0.36

17.45

1.7

1.4

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

8876

56166

1.14

17.42

2.9

3.2

140.20

160.78

ug/l

12.28

7811

50860

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

8107

51034

1.14

17.15

5.6

6.7

4.60

4.37

ug/l

0.11

7010

45346

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

10774

69065

1.13

17.12

3.1

3.4

48.65

58.93

u/l

24.03

9647

62601

(3007164) IgA [Mass/volume] in Serum or Plasma

2654

21406

0.83

17.11

1.4

1.5

2.73

2.70

g/l

0.16

1293

11751

(3018095) Leukocytes [#/volume] in Urine

8628

54548

1.14

17.04

4.5

4.4

141.95

132.66

e6/l

0.30

6348

39905

(3013139) Helicobacter pylori Ag [Presence] in Stool

933

8491

0.74

16.77

1.3

—

(21494755) Public health laboratory ask at order entry panel

103

1627

0.43

16.65

1.3

1.4

—

(3047181) Lactate [Moles/volume] in Blood

925

4705

1.36

16.35

4.3

5.9

1.40

1.34

mmol/l

0.68

834

4192

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

7144

44706

1.14

16.32

2.4

2.7

156.50

62.19

u/l

0.55

6529

41027

(4281824) Cell count and differential, peritoneal fluid

1509

0.42

16.11

1.1

1.2

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

295

3318

0.60

16.07

2.2

205.20

213.18

0.78

271

3140

(3007566) Smooth muscle Ab [Titer] in Serum

272

3115

0.59

15.94

1.1

1.2

87.83

133.81

titre

1.51

244

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

320

3517

0.62

15.83

1.8

2.0

91.51

88.80

1.60

298

3378

(3039000) Anion gap in Blood by calculation

670

3251

1.42

15.67

4.5

6.8

11.45

11.26

mmol/l

0.64

612

2932

(3018572) Chloride [Moles/volume] in Blood

670

3251

1.42

15.67

4.5

6.8

105.07

104.79

mmol/l

0.72

612

2933

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

303

3350

0.61

15.38

1.2

1.3

3.23

4.56

u/ml

0.42

342

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

303

3347

0.61

15.32

1.3

2.98

4.69

u/ml

1.94

518

(3022621) pH of Urine by Test strip

1903

10728

1.23

15.25

3.5

3.1

6.11

6.04

3.08

1434

7666

(40768797) Stomach Pathology biopsy report

2409

19404

0.83

15.14

1.3

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

2652

21170

0.84

15.07

3.0

4.2

246.78

248.96

u/l

0.25

2400

20029

(3034770) Mitochondria Ab [Titer] in Serum

278

3121

0.60

15.06

1.1

1.2

790.00

919.46

titre

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

327

3525

0.63

14.88

1.2

42.74

40.56

u/ml

0.04

171

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

584

5614

0.70

14.83

1.2

1.3

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2562

14918

1.20

14.78

3.2

221.18

262.10

ng/l

4.77

2362

13821

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2135

12219

1.22

14.76

1.6

—

(36304419) Bacteria [Presence] in Urine

6503

40678

1.13

14.52

3.7

3.6

981.94

201.52

estimate

0.37

265

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

567

5443

0.71

14.29

1.5

1.7

37.73

38.32

u/l

0.25

470

4612

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

713

6588

0.73

14.18

2.7

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

162

2053

0.54

13.82

1.7

2.1

459.67

5727.37

u/ml

0.77

143

(46235355) HIV 1 and 2 tests - Meaningful Use set

1361

11502

0.80

13.70

1.4

1.5

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

217

2529

0.58

13.69

1.7

1.8

14.94

25.44

ug/l

11.01

211

2459

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

172

2130

0.55

13.57

1.2

1.3

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

270

2972

0.62

13.50

1.2

1.80

5.62

u/ml

1.78

205

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2809

22100

0.85

13.26

3.7

5.5

1.01

1.04

mmol/l

8.19

2500

20331

(40768793) Breast Pathology biopsy report

275

2995

0.62

13.14

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

332

3465

0.65

13.06

1.2

1.3

—

(40768443) Skin Pathology biopsy report

764

6898

0.75

13.00

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

5512

34325

1.13

12.90

3.6

3.5

0.11

0.08

0.54

234

1258

(3045142) Bone marrow Pathology biopsy report

162

2006

0.55

12.80

1.2

1.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

302

3198

0.64

12.73

1.2

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

187

2220

0.57

12.69

1.4

1.5

210.97

257.47

pmol/l

0.40

180

2158

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

116

1586

0.50

12.67

1.0

1.1

1.56

1.58

g/l

0.24

105

1421

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1400

7806

1.24

12.39

3.9

4.9

1.61

1.53

1.49

1342

7441

(3027945) Reticulocytes/Erythrocytes in Blood

3577

21696

1.15

12.33

2.0

2.4

1.73

1.79

2.78

2996

19141

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

335

3439

0.66

12.18

1.7

1.8

12.13

12.99

mg/l

0.94

297

3153

(3007930) Methemoglobin/Hemoglobin.total in Blood

1292

7154

1.25

12.17

4.0

5.1

0.90

0.85

3.18

1235

6796

(3015171) Extractable nuclear Ab [Units/volume] in Serum

452

4384

0.70

12.14

1.3

1.2

0.47

0.95

u/ml

1.70

381

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

8682

63264

0.90

12.12

2.6

3.0

—

estimate

—

(4094501) Cardiovascular stress test using bicycle ergometer

319

3296

0.66

11.98

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

163

1974

0.56

11.94

1.4

1.6

0.67

0.86

g/l

1.64

122

1502

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

1345

11210

0.81

11.87

2.6

3.0

58.93

57.16

ml/min/173m2

1.16

592

5165

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

159

584

1.87

11.69

1.1

38.64

47.69

mg/l

1.79

130

501

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

201

2287

0.60

11.61

1.1

—

(3000494) Fungus identified in Specimen by Culture

1975

15818

0.84

11.44

1.4

1.5

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

373

3703

0.68

11.43

1.7

1.5

1.15

1.17

g/l

0.77

349

3517

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

363

3614

0.68

11.30

1.6

1.5

0.23

g/l

0.38

337

3419

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

16966

112867

1.13

11.26

5.6

6.2

6.17

6.13

mmol/l

2.56

14878

100397

(4027681) Cerebrospinal fluid IgG ratio and IgG index

115

384

2.06

11.10

1.2

0.50

0.52

ratio

0.42

228

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

132

465

1.95

11.01

2.3

2.2

58.56

52.80

umol/l

1.12

105

376

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

171

1998

0.58

10.99

1.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

140

1717

0.56

10.78

1.3

156.56

159.84

au/ml

0.15

517

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1282

10631

0.81

10.76

5.4

8.0

24.22

24.31

mmol/l

0.41

1229

10308

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

742

6549

0.77

10.71

2.1

2.7

0.39

0.35

iu/ml

1.88

422

3687

(3003434) Protein [Mass/volume] in Pleural fluid

326

3275

0.68

10.67

1.3

1.5

30.55

31.47

g/l

0.73

289

2954

(3000850) Epithelial cells [#/volume] in Urine

5660

35629

1.12

10.65

2.9

5.65

4.97

e6/l

3.46

5181

32383

(3020191) Ethanol [Moles/volume] in Serum or Plasma

182

718

1.74

10.65

1.3

1.2

0.80

1.00

promille

1.18

151

552

(3004809) Band form neutrophils/Leukocytes in Blood

292

2995

0.66

10.63

3.4

3.6

1.86

1.56

0.53

236

2645

(40768441) Liver Pathology biopsy report

916

0.40

10.61

1.1

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

301

2.17

10.50

1.2

1.3

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

214

2333

0.62

10.38

1.2

58.24

46.33

u/ml

0.47

235

(40768800) Prostate Pathology biopsy report

396

3820

0.70

10.36

1.1

1.2

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

179

2021

0.60

10.08

1.3

0.35

0.27

nmol/l

0.36

161

(3030467) Casts [#/volume] in Urine by Automated count

6868

43802

1.11

9.97

3.7

0.54

0.48

e6/l

1.03

5226

33095

(40768795) Lymph node Pathology biopsy report

120

1502

0.54

9.96

1.2

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

233

2.30

9.93

15.7

12.5

0.66

0.65

mmol/l

0.11

213

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1063

8908

0.81

9.88

2.1

2.2

11.50

11.69

nmol/l

0.26

875

7579

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

163

2.57

9.82

1.1

1.3

25.14

50.22

2.78

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

145

550

1.81

9.72

1.1

272.33

321.86

mg/l

2.17

123

486

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

194

2124

0.62

9.62

3.2

3.6

28.21

45.46

u/ml

2.62

185

2065

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

177

1980

0.61

9.62

1.3

11.00

1.94

nmol/l

0.42

164

1892

(3023419) Bacteria identified in Sputum by Culture

215

2296

0.64

9.54

2.3

2.5

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

151

584

1.77

9.51

1.1

—

(4034850) Laboratory test

705

3740

1.30

9.47

13.4

13.3

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

439

4099

0.73

9.45

2.1

2.7

1.67

1.85

mg/l

4.68

352

3625

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

4056

25197

1.12

9.45

3.5

2.65

2.49

e6/l

0.41

2070

12957

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

522

0.26

9.44

1.3

1.2

0.55

0.59

ratio

—

158

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

123

1503

0.56

9.42

1.1

1.2

38.30

37.23

u/ml

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

6417

40882

1.10

9.39

4.9

5.4

22.03

22.53

1.77

3366

23242

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

154

1771

0.59

9.38

1.3

0.19

0.20

nmol/l

0.70

124

1443

(3048929) Epstein Barr virus Ab [Presence] in Serum

193

2094

0.63

9.22

1.1

1.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

401

1961

1.41

9.17

7.2

10.6

8.17

7.37

mmol/l

1.36

320

1630

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

194

2.37

9.17

16.2

14.9

1032.10

1277.66

nmol/l

1.63

188

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

379

3603

0.71

9.14

1.5

31.85

4.34

iu/ml

1.04

106

806

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

149

1714

0.59

9.10

1.1

1.2

—

83.99

—

(3026782) Osmolality of Urine

4920

30973

1.11

8.99

3.2

540.20

526.48

mosm/kgh2o

4.92

4325

27135

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

938

0.46

8.96

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

317

3094

0.70

8.94

1.3

1.5

—

(40768806) Pleura Pathology biopsy report

235

2427

0.66

8.93

1.4

1.6

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

255

1152

1.52

8.78

1.2

1.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

251

1131

1.52

8.75

1.2

1.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

603

3174

1.31

8.62

1.6

2.2

25.58

33.15

umol/l

14.56

494

2760

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

691

0.39

8.59

1.2

1.3

1.55

1.53

g/l

0.15

691

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

4381

27475

1.11

8.54

3.4

1.43

1.28

e6/l

0.60

2415

15278

(3023199) Leukocytes [#/volume] in Pleural fluid

287

2821

0.69

8.44

1.3

1.5

3160.67

2444.48

e6/l

0.32

206

1989

(3042936) Bacteria identified in Isolate by Culture

2841

21686

0.88

8.44

1.9

2.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

139

1581

0.60

8.17

1.1

1.2

261.21

286.60

u/ml

0.55

916

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

670

5780

0.79

8.12

1.1

1.2

83.98

122.04

u/ml

2.06

209

1847

(3036489) Thrombin time

533

4724

0.77

8.03

1.6

1.8

21.26

21.70

0.63

474

4311

(3036782) Glucose [Moles/volume] in Pleural fluid

208

2149

0.66

7.97

1.2

1.4

6.22

6.39

mmol/l

0.40

188

2022

(3044889) 12 lead EKG panel

13197

87247

1.09

7.96

5.1

5.0

0.64

560.72

0.62

217

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

132

519

1.75

7.95

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

931

0.49

7.89

1.2

1.1

0.46

1.11

u/ml

1.63

540

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

155

643

1.65

7.70

1.2

1.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

571

3033

1.30

7.68

4.1

3.8

31.50

29.55

mg/l

0.58

429

2168

(3027456) Digoxin [Moles/volume] in Serum or Plasma

861

4807

1.23

7.63

3.8

3.3

0.77

0.82

nmol/l

3.47

676

3894

(21494434) Karyotype in Bone marrow

151

1654

0.62

7.61

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

759

0.45

7.57

2.1

2.3

12.82

29.61

iu/ml

2.49

142

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

108

407

1.82

7.51

3.2

2.7

28.22

28.97

umol/l

0.29

306

(3023487) Leukocytes [#/volume] in Peritoneal fluid

620

0.40

7.49

1.5

1.9

4693.32

3170.93

e6/l

0.14

416

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

135

544

1.70

7.49

1.6

2.0

52.84

57.73

ug/l

0.51

130

534

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

327

3074

0.72

7.44

1.2

1.3

170.27

261.54

titre

1.27

234

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

537

0.36

7.42

1.5

1.8

10306.41

16758.46

e6/l

0.40

290

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

184

1913

0.66

7.32

3.4

3.6

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

124

493

1.73

7.23

1.5

104.62

91.15

umol/l

0.36

277

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

329

3072

0.73

7.19

1.2

1.3

88.00

161.23

titre

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

4853

35705

0.91

7.17

2.3

2.7

—

(3042631) Mycobacterium sp identified in Specimen

268

2583

0.71

7.12

2.5

2.8

—

(3008898) HLA-B27 [Presence]

195

1989

0.67

7.07

1.0

—

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

2.91

7.00

1.3

1.4

50.17

41.85

0.39

(21494815) CD4 cells/Lymphocytes in Specimen

938

0.52

6.99

2.1

1.9

39.13

36.83

0.67

913

(3028192) IgG subclass 2 [Mass/volume] in Serum

105

1227

0.58

6.95

1.2

1.4

2.80

2.90

g/l

0.25

872

(3027135) IgG subclass 1 [Mass/volume] in Serum

105

1226

0.58

6.93

1.2

1.4

6.75

7.10

g/l

0.40

870

(3024139) IgG subclass 3 [Mass/volume] in Serum

105

1226

0.58

6.93

1.2

1.4

0.39

0.45

g/l

1.08

871

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

139

1516

0.63

6.92

2.7

4.2

40.91

66.93

u/ml

1.15

132

1484

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

156

1658

0.64

6.92

1.3

—

nmol/l

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

277

2641

0.71

6.91

1.3

1.2

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

225

2220

0.69

6.85

1.2

1.3

397.06

422.92

u/l

0.12

209

2107

(1002224) Polysomnography panel

262

2516

0.71

6.83

1.1

—

(3025130) Human papilloma virus identified in Specimen

793

0.49

6.80

1.8

1.6

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

325

3013

0.73

6.80

1.3

1.4

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

263

2520

0.71

6.77

1.3

1.5

53065.36

64705.96

e6/l

0.36

157

1428

(3037577) Monocytes/Leukocytes in Cerebral spinal fluid

3.07

6.74

1.2

1.4

13.41

15.31

0.16

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

114

1293

0.60

6.72

1.1

1.2

93.50

79.15

u/ml

—

(3044640) Blood type and Crossmatch panel - Blood

6449

46748

0.92

6.69

2.4

2.7

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

568

0.41

6.64

1.3

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

163

1700

0.65

6.63

1.1

1.2

61.50

60.65

u/l

0.06

134

1490

(3022640) Eosinophils/Leukocytes in Cerebral spinal fluid

3.24

6.62

1.3

1.07

1.82

0.33

(3045788) Cell count panel - Pleural fluid

232

2261

0.70

6.61

1.3

1.5

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

10554

75037

0.93

6.60

6.7

9.7

4.58

4.39

e9/l

10.16

9026

64086

(3043409) Potassium [Moles/volume] in Arterial blood

814

4594

1.22

6.56

3.7

4.2

3.91

mmol/l

0.15

809

4549

(3011412) CD3 cells [#/volume] in Blood

1118

0.58

6.49

2.3

1.9

1094.89

1144.84

e6/l

0.15

1015

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

1099

0.58

6.46

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

298

1.89

6.45

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

168

1730

0.66

6.43

1.0

—

(4062490) Immunoglobulin typing, IgG

105

1201

0.60

6.42

1.2

1.4

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

179

1818

0.67

6.40

1.1

1.3

241.21

271.01

pmol/l

1.06

141

1499

(3004616) Nuclear Ab [Presence] in Serum

165

1702

0.66

6.38

1.2

1.3

—

(3024354) Oxygen [Partial pressure] in Venous blood

2380

14649

1.13

6.34

2.6

3.1

4.21

4.39

kpa

4.12

2311

14233

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

134

1439

0.64

6.28

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

636

3517

1.24

6.23

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

636

3517

1.24

6.23

1.4

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

312

1.85

6.20

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

720

0.49

6.17

1.0

1.1

0.58

0.80

u/ml

0.32

324

(3002030) Lymphocytes/Leukocytes in Blood

8800

62882

0.93

6.13

5.2

6.5

24.45

25.31

10.38

8155

59018

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

301

1508

1.37

6.13

1.6

1.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

554

4720

0.80

6.11

1.6

1.7

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

273

2554

0.73

6.11

1.3

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

390

3461

0.77

6.04

1.4

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

157

697

1.55

6.01

1.6

1.4

14.77

15.05

umol/l

0.16

145

644

(3044007) Cell count panel - Peritoneal fluid

522

0.42

5.94

1.6

1.8

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

322

1.81

5.91

1.1

—

(3033658) Prothrombin time (PT) actual/Normal

4873

35586

0.92

5.90

3.6

4.4

81.16

83.18

6.49

4755

34895

(3017354) Segmented neutrophils/Leukocytes in Blood

200

1958

0.70

5.90

2.7

3.7

59.59

58.63

0.24

149

1660

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

119

1292

0.63

5.89

1.1

—

(3018405) Lactate [Moles/volume] in Arterial blood

961

5572

1.19

5.86

3.4

3.9

1.41

1.40

mmol/l

0.02

940

5458

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

973

0.58

5.83

1.1

1.2

258.00

139.82

titre

0.52

163

(3003888) Timothy IgE Ab [Units/volume] in Serum

733

0.51

5.83

1.0

1.1

1.92

1.94

u/ml

0.00

358

(3006315) Basophils [#/volume] in Blood

9409

66986

0.93

5.79

4.9

6.1

0.04

e9/l

2.56

7928

56022

(3048689) Calprotectin [Mass/mass] in Stool

1719

13234

0.88

5.79

1.8

2.0

177.63

166.74

ug/g

0.42

1258

10222

(3010726) Horse dander IgE Ab [Units/volume] in Serum

583

0.46

5.78

1.1

0.21

0.53

u/ml

1.36

324

(3001604) Monocytes [#/volume] in Blood

9367

66677

0.93

5.71

4.9

6.1

0.63

e9/l

1.84

7886

55685

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

122

1302

0.64

5.61

1.2

—

(3042733) HLA Ab [Presence] in Serum

208

0.23

5.56

7.0

4.8

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

323

2903

0.76

5.54

1.3

1.6

—

(3013115) Eosinophils [#/volume] in Blood

9645

68539

0.93

5.52

5.0

6.3

0.19

0.20

e9/l

0.51

8203

58233

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

184

1802

0.70

5.48

1.1

1.2

2.29

4.22

u/ml

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

780

0.54

5.47

1.5

1.3

1.11

1.65

u/ml

0.38

480

(3016650) Hepatitis A virus Ab [Presence] in Serum

162

1622

0.68

5.45

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

216

2056

0.72

5.44

1.6

1.7

53.27

48.95

nmol/l

1.42

208

1944

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

919

0.58

5.43

1.1

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

133

1383

0.66

5.42

1.7

1.8

4.30

4.53

mg/l

0.24

121

1316

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

149

671

1.52

5.40

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

469

0.42

5.32

1.0

1.1

1.82

1.62

u/ml

0.04

217

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

790

0.55

5.30

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

497

0.44

5.30

1.1

1.8

222839.00

32508.29

u/ml

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

355

1.72

5.26

1.4

1.5

16.53

16.78

pmol/l

0.13

285

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

222

2091

0.72

5.26

1.5

1.4

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

330

1.74

5.23

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

874

0.58

5.22

1.1

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1484

8979

1.14

5.22

3.7

4.4

44.35

45.92

1.73

1469

8849

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

856

0.57

5.21

1.2

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

856

0.57

5.21

1.2

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

856

0.57

5.21

1.2

1.6

—

(3020876) Protein [Mass/time] in 24 hour Urine

253

2332

0.74

5.21

2.0

2.4

0.90

1.04

g/24h

0.43

115

1340

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

873

0.58

5.20

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

899

0.58

5.20

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

160

1590

0.69

5.19

1.4

1.3

10.63

12.97

u/l

1.49

120

1256

(3014007) Fractional oxyhemoglobin in Arterial blood

1466

11320

0.88

5.18

5.8

8.4

93.34

93.70

1.26

1457

11286

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

137

1401

0.67

5.17

1.2

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

137

1401

0.67

5.17

1.2

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

137

1401

0.67

5.17

1.2

1.5

—

(3022096) Basophils/Leukocytes in Blood

8727

62133

0.94

5.16

5.2

6.5

0.62

0.64

3.58

7950

57690

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

251

2305

0.74

5.05

1.4

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

182

1756

0.71

5.01

1.2

1.3

21.13

12.72

u/l

1.66

166

1618

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2076

12856

1.12

4.99

2.7

3.9

85.14

98.65

ng/l

11.20

1663

10766

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

843

0.58

4.94

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

859

0.59

4.92

1.1

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

13608

90800

1.07

4.91

26.5

26.8

13.96

14.03

5.82

13416

89526

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

327

1.72

4.88

1.1

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

3587

26344

0.92

4.87

2.2

3.0

0.82

0.81

mmol/l

1.10

3223

24509

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

501

4201

0.81

4.85

1.6

31.64

30.78

u/ml

0.05

625

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

1043

0.63

4.85

1.1

1.2

—

(3011985) Renin [Units/volume] in Plasma

206

1936

0.73

4.85

1.2

1.4

40.33

59.53

mu/l

1.29

173

1722

(3019069) Monocytes/Leukocytes in Blood

8759

62270

0.94

4.84

5.2

6.5

9.14

9.21

1.14

7983

57749

(3006504) Eosinophils/Leukocytes in Blood

8733

62086

0.94

4.83

5.1

6.4

2.76

2.81

0.88

7960

57603

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

854

0.59

4.81

1.1

1.6

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

401

0.41

4.81

1.3

27.53

45.58

g/l

0.67

329

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

391

1.65

4.80

1.4

1.2

102.42

134.23

nmol/l

1.35

272

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

136

1370

0.68

4.78

1.2

7.00

4.73

u/ml

0.34

504

(4268621) Lupus anticoagulant assay

928

0.61

4.75

2.0

2.3

—

(3018333) Ribosomal P Ab [Presence] in Serum

832

0.59

4.72

1.1

—

(3035880) pH of Pleural fluid

120

1234

0.66

4.70

1.2

1.3

7.43

7.41

0.41

877

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

923

0.61

4.66

1.3

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

922

0.61

4.64

1.3

1.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

341

2968

0.78

4.63

1.3

1.4

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

987

0.63

4.59

1.1

1.2

83.13

97.91

u/l

0.84

838

(3019198) Lymphocytes [#/volume] in Blood

9581

67843

0.94

4.57

5.0

6.2

1.74

1.85

e9/l

4.70

8236

58146

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

406

2217

1.26

4.56

1.1

6.44

13.12

eliau/ml

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

567

0.52

4.51

1.2

—

(3004775) Volume in Urine collected for unspecified duration

134

1336

0.68

4.49

2.1

2.2

622.58

663.16

0.55

843

(3029075) Extractable nuclear Ab panel - Serum

664

0.56

4.48

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1005

0.64

4.46

3.4

3.8

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

195

1.90

4.45

1.1

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

266

1380

1.32

4.45

2.2

2.01

1.89

u/field

0.15

150

728

(3008116) Ketones [Moles/volume] in Urine by Test strip

290

1.73

4.44

1.3

1.4

0.23

0.30

mmol/l

0.54

(3008295) Osmolality of Serum or Plasma

319

1697

1.29

4.44

1.3

275.71

274.57

mosm/kgh2o

0.31

217

1247

(21494890) Protein electrophoresis panel - 24 hour Urine

221

2025

0.74

4.44

1.8

2.1

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5482

39488

0.93

4.42

2.7

3.2

33.78

36.32

u/l

1.12

5078

36749

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

181

1.93

4.42

1.1

1.2

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

225

1.83

4.42

1.9

2.5

137.66

125.58

nmol/l

0.43

196

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

113

503

1.54

4.40

1.1

30.12

588.45

ng/l

1.57

157

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

16492

110901

1.07

4.38

7.3

7.9

41.20

40.67

mmol/mol

9.50

14753

101020

(40768446) Kidney Pathology biopsy report

394

0.43

4.37

1.1

1.5

—

(3016750) Collection duration of Urine

939

0.63

4.32

2.0

2.1

487.81

499.64

min

0.37

652

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

619

0.55

4.27

1.1

1.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

619

0.55

4.27

1.1

1.7

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

683

5492

0.85

4.26

2.1

2.5

0.00

g/l

0.16

570

4773

(3026692) Albumin [Mass/volume] in Peritoneal fluid

455

0.48

4.25

1.3

1.4

13.98

14.85

g/l

0.21

354

(3028717) Thiamine [Mass/volume] in Blood

132

2.08

4.23

1.1

64.68

63.25

ug/l

0.16

132

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

171

1615

0.72

4.21

1.8

183.01

189.44

pmol/l

0.48

149

1472

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1397

10674

0.89

4.20

4.4

6.9

24.85

24.78

mmol/l

0.24

1379

10582

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

966

0.64

4.20

1.1

1.2

28.39

30.04

u/l

0.12

806

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

495

4088

0.82

4.17

1.3

1.5

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

830

0.62

4.17

2.2

1.8

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

488

0.50

4.15

1.0

1.1

0.76

1.74

u/ml

0.73

247

(3023520) Reticulocytes [#/volume] in Blood

2724

17259

1.09

4.14

2.0

2.5

64.96

67.97

e9/l

4.69

2051

12836

(3000991) Gas panel - Venous blood

1976

14799

0.91

4.11

4.8

7.8

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

558

0.54

4.10

1.4

1.7

89.51

98.17

1.08

533

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

242

0.31

4.04

12.6

5.90

5.22

mmol/l

0.88

242

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

713

5683

0.85

4.01

2.0

2.5

0.02

0.04

g/l

0.93

606

5066

(3038026) Centromere Ab [Units/volume] in Serum

109

1103

0.67

4.00

1.1

1.2

62.02

56.52

u/ml

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

118

1175

0.69

3.98

1.1

115.80

115.26

0.06

101

1026

(3034092) Cytoplasmic Ig cells/cells in Blood

108

2.16

3.97

13.4

11.8

0.29

0.23

0.55

108

(3018010) Neutrophils/Leukocytes in Blood

8676

61440

0.94

3.94

5.1

6.4

60.12

59.15

10.58

8061

58209

(40758292) HTLV I+II Ab panel - Serum

192

0.32

3.92

1.2

1.3

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

193

0.32

3.92

1.2

1.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

223

2001

0.76

3.91

1.1

1.2

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

908

7092

0.87

3.88

2.7

3.4

49.70

73.80

mg/l

1.95

741

6038

(3039162) Centromere protein B Ab [Units/volume] in Serum

150

1424

0.72

3.86

1.3

1.2

51.99

60.06

u/ml

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

168

1566

0.73

3.85

1.3

1.4

14.42

13.57

u/l

0.87

159

1507

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

625

0.58

3.84

1.2

1.8

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

829

0.63

3.83

1.0

1.1

—

(3003181) Sodium [Moles/volume] in Urine

599

3471

1.19

3.82

1.3

1.4

64.33

59.94

mmol/l

2.01

482

2801

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

575

3321

1.19

3.80

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

580

3354

1.19

3.79

1.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

517

0.54

3.78

2.6

2.4

0.62

mmol/l

0.11

517

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

11193

74554

1.06

3.77

4.4

6.9

12.26

12.47

umol/l

0.82

10452

71105

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

681

0.60

3.75

2.6

2.5

40.06

35.62

1.03

396

(42529406) Shigella sp [Presence] in Stool by Culture

581

3364

1.19

3.74

1.2

—

(40757373) Influenza virus identified in Isolate

274

1.68

3.74

1.4

1.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

726

4282

1.17

3.74

2.1

2.3

127.02

125.94

g/l

0.57

593

3257

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

397

0.48

3.74

1.0

1.1

0.42

0.23

u/ml

—

179

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

192

1746

0.75

3.73

1.1

1.2

—

33.43

u/ml

—

(3003129) Base excess in Capillary blood by calculation

226

2010

0.77

3.73

2.0

2.5

0.96

0.43

mmol/l

1.32

209

1945

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

433

0.51

3.72

1.1

1.4

118.72

174.11

pmol/l

1.25

433

(3000919) Neutrophils/Leukocytes in Pleural fluid

636

0.59

3.71

1.2

1.4

23.38

18.97

0.53

569

(3021162) Amylase [Enzymatic activity/volume] in Specimen

271

0.38

3.70

1.7

2.6

545.20

1002.47

u/l

0.39

248

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

910

7081

0.87

3.70

2.7

3.4

44.47

48.94

mg/l

0.43

746

6022

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

255

2230

0.78

3.69

1.4

1.7

5.79

4.73

mg/l

0.47

199

1704

(3004119) Hemoglobin [Mass/volume] in Venous blood

1724

10753

1.11

3.67

2.7

3.3

128.20

126.15

g/l

3.78

1673

10418

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

935

0.66

3.65

1.1

94.48

92.74

0.29

858

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

286

0.41

3.57

1.1

1.3

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

354

2970

0.81

3.56

1.3

36.48

41.97

u/l

0.42

305

2547

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

214

0.32

3.53

1.2

1.1

—

(3024471) HLA-A [Type]

224

0.34

3.52

1.0

—

(3047189) Immunofixation for 24 hour Urine

902

0.67

3.50

1.2

1.7

—

(3024932) HLA-DR beta [Type]

213

0.32

3.50

1.2

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

568

3308

1.18

3.45

1.4

0.28

0.30

mg/l

0.32

237

1335

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

15168

105590

0.95

3.44

4.2

4.8

1.20

1.25

mmol/l

23.46

13129

93168

(3017732) Neutrophils [#/volume] in Blood

2168

16024

0.92

3.40

3.1

3.2

5.01

4.96

e9/l

0.10

1700

13142

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

8416

55732

1.05

3.40

3.1

3.5

1918.46

1847.97

ng/l

0.65

7251

49295

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

646

5113

0.86

3.37

2.1

2.5

0.00

g/l

-0.00

568

4762

(3012565) Volume of 24 hour Urine

720

0.64

3.36

1.9

2.2

1695.21

1794.71

0.34

607

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

425

0.53

3.32

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

425

0.53

3.32

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

425

0.53

3.32

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

425

0.53

3.32

1.2

1.1

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

168

1527

0.75

3.31

2.0

2.3

676.55

821.50

0.76

168

1509

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

607

0.61

3.30

1.1

83.83

83.00

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1509

11320

0.91

3.28

5.6

8.2

1.37

1.28

3.26

1501

11244

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

904

0.68

3.26

4.7

5.5

18.64

114.34

u/ml

4.38

272

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

121

1153

0.72

3.25

1.3

1.4

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

894

0.68

3.23

1.1

24.65

26.34

u/l

0.14

764

(3044242) Glucose [Moles/volume] in Arterial blood

191

995

1.32

3.22

1.8

1.9

8.64

7.98

mmol/l

0.98

191

995

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

704

0.64

3.22

2.1

2.0

486.45

565.71

e6/l

0.50

579

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

901

0.68

3.21

1.1

81.61

85.84

u/l

0.28

775

(3035715) Granulocytes [#/volume] in Blood

278

2363

0.80

3.21

2.5

3.2

4.71

4.42

e9/l

0.96

278

2356

(40765096) Chromosome analysis panel by Banding

507

0.58

3.19

1.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

108

514

1.44

3.17

2.1

2.5

9.55

10.09

kpa

1.53

108

514

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

108

514

1.44

3.17

2.1

2.5

4.81

5.00

kpa

1.01

108

514

(3008757) Leukocyte morphology finding [Identifier] in Blood

202

1779

0.78

3.16

3.9

3.8

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1459

9098

1.10

3.16

2.2

2.7

1.11

1.15

1.46

1452

9054

(3033099) Centromere Ab [Titer] in Serum

317

0.47

3.14

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

184

1.75

3.12

2.9

0.51

0.49

u/field

0.04

184

(44813793) Dust mix specific IgE antibody measurement

665

0.64

3.11

1.0

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

935

0.69

3.10

1.4

1.5

5.55

7.15

u/l

0.56

740

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

361

0.51

3.09

2.4

2.3

4.19

768.98

ug/l

1.58

361

(3024891) Influenza virus A+B Ag [Presence] in Specimen

450

2597

1.19

3.08

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

754

0.66

3.07

1.4

1.6

—

(3045414) Leukocytes [Presence] in Urine

2246

14300

1.08

3.07

2.2

0.01

estimate

0.06

315

2527

(3005532) Lymphocytes/Leukocytes in Pleural fluid

802

0.67

3.05

1.2

1.4

60.59

66.60

0.71

659

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1446

9030

1.10

3.05

2.2

2.7

0.65

0.63

1.33

1440

8997

(3001893) Eosinophils/Leukocytes in Pleural fluid

703

0.65

3.05

1.3

1.4

3.46

2.34

0.44

591

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

508

4058

0.85

3.03

1.3

1.5

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

698

0.66

2.96

2.1

238.51

245.29

e6/l

0.11

619

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

15853

110075

0.95

2.96

4.8

5.6

1.46

1.45

mmol/l

2.77

13939

98592

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

146

1328

0.75

2.94

1.2

4.52

4.40

u/ml

0.04

610

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1467

10956

0.91

2.93

5.7

8.5

0.67

0.62

4.36

1457

10889

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

766

0.68

2.85

1.0

295.15

294.78

mg/l

0.01

678

(4195642) Thrombophilia screening test

127

1168

0.74

2.78

1.2

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

118

0.29

2.77

1.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

537

0.62

2.75

1.1

1.2

146.65

158.06

mmol/24h

0.39

537

(3020630) Protein [Mass/volume] in Serum or Plasma

2178

15950

0.93

2.75

2.3

2.7

65.54

65.79

g/l

0.79

1837

14417

(3006922) Hepatitis E virus Ab [Presence] in Serum

727

0.68

2.75

1.0

1.1

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1055

7973

0.90

2.71

2.0

2.4

3.78

3.72

g/l

0.53

872

7173

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

114

1059

0.74

2.68

1.2

233.08

208.68

miu/ml

0.14

231

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1058

7990

0.90

2.68

2.0

2.4

4.13

4.17

g/l

1.01

875

7193

(3022689) Creatine [Moles/volume] in Urine

431

0.59

2.68

1.2

1.4

6.78

6.85

mmol/l

0.03

431

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

137

1.80

2.66

1.1

—

(3012544) pH of Venous blood

2761

17814

1.07

2.65

2.8

3.8

7.38

1.66

1586

10534

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2074

13245

1.08

2.65

2.8

2.6

0.58

0.50

e6/l

0.85

2003

12826

(3028707) Methadone [Presence] in Urine by Screen method

258

1.57

2.64

1.9

1.4

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

1312

8220

1.10

2.63

3.0

3.6

25.32

25.14

mmol/l

1.14

1268

7981

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1060

7995

0.90

2.63

2.0

2.4

7.56

7.49

g/l

0.59

875

7188

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

106

991

0.73

2.61

1.3

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

249

2086

0.81

2.58

1.4

1.5

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

135

1216

0.76

2.58

1.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

832

6347

0.89

2.56

2.6

3.3

2.87

6.92

ratio

1.37

534

3737

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

674

0.68

2.54

5.7

6.6

32.02

136.84

ug/l

1.17

433

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2474

15934

1.07

2.51

4.4

3.9

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

105

1.89

2.51

1.1

1.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

615

0.67

2.50

1.4

1.6

—

(21491868) Cryoglobulin [Mass/volume] in Serum

482

0.62

2.50

1.3

1.2

1.16

0.46

g/l

—

(3008536) Aspergillus sp Ab [Presence] in Serum

309

0.53

2.50

1.3

1.6

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

126

1140

0.76

2.50

1.1

0.96

2.12

iu/ml

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

235

1.57

2.48

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

496

0.63

2.45

1.4

1.3

35.32

34.49

u/l

0.05

417

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

717

0.70

2.44

1.2

1.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

252

0.49

2.44

1.9

1.6

2.16

2.36

ug/l

0.09

150

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

112

1025

0.75

2.42

1.3

1.5

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2724

17624

1.07

2.42

2.8

3.8

5.82

5.81

kpa

0.20

2653

17187

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2.06

2.41

1.1

14.80

26.84

nmol/l

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

296

0.53

2.41

1.1

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

147

1.72

2.41

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

443

3503

0.86

2.40

1.6

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

138

721

1.31

2.39

1.2

1.3

1.20

nmol/l

0.01

524

(3038071) Oxygen [Partial pressure] in Mixed venous blood

304

0.54

2.39

5.9

7.9

6.11

5.57

kpa

0.39

304

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

110

1005

0.75

2.36

1.2

7.87

8.06

mmol/l

0.24

800

(3032352) Blasts [#/volume] in Cerebral spinal fluid

142

0.39

2.35

1.3

1.6

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

614

0.68

2.34

1.1

—

(3003577) Lead [Moles/volume] in Blood

2.33

2.32

1.2

1.1

0.11

0.10

umol/l

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

2554

16518

1.07

2.30

5.1

7.5

119.98

119.11

g/l

1.44

2492

16154

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

109

993

0.75

2.30

1.3

1.5

—

(3002032) Base excess in Venous blood by calculation

2648

17148

1.06

2.29

2.8

3.8

1.96

1.79

mmol/l

1.41

2323

14948

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

361

0.59

2.29

6.3

7.9

5.68

5.93

kpa

1.36

304

(3036048) Francisella tularensis Ab [Titer] in Serum

246

0.50

2.29

1.1

1.2

—

1229.09

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

218

0.47

2.28

1.1

1.0

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

698

0.70

2.26

1.6

1.5

5.21

6.17

u/l

1.66

572

(3038177) Helicobacter pylori Ab [Presence] in Serum

159

1375

0.79

2.26

1.5

1.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

181

1540

0.80

2.23

1.1

—

(3028271) Lactate [Moles/volume] in Capillary blood

442

2627

1.15

2.22

1.8

1.9

1.78

1.71

mmol/l

0.89

435

2551

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

441

1.38

2.20

1.1

1.04

1.14

u/l

1.37

201

(3010370) Gastrin [Moles/volume] in Serum or Plasma

204

0.47

2.16

2.9

1.6

53.86

57.18

pmol/l

0.07

156

(3004716) Salmonella sp identified in Stool by Organism specific culture

638

3894

1.12

2.15

1.2

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

0.00

2.13

0.0

1.8

—

2.00

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

114

592

1.32

2.10

1.2

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

102

1.81

2.10

1.1

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

192

0.46

2.09

1.8

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1170

7379

1.09

2.09

2.3

2.5

28.59

24.39

au/ml

0.47

512

(3001964) Herpes simplex virus Ag [Presence] in Specimen

351

0.60

2.08

1.4

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

418

0.64

2.08

1.4

1.6

106.79

114.49

ug/l

0.17

351

(3032057) Clostridioides difficile [Presence] in Stool

373

1.40

2.01

1.7

1.8

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

177

1490

0.81

2.01

1.2

1.6

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2201

15928

0.94

2.01

2.1

2.6

8.41

10.17

umol/l

3.78

1863

14057

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

583

4466

0.89

2.00

1.6

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

380

0.63

1.99

1.6

1.4

77.86

250.63

nmol/24h

1.42

380

(1617658) Protocol used for examination of sentinel lymph nodes

875

0.76

1.97

1.1

—

(3021788) Differential panel - Synovial fluid

377

2965

0.87

1.96

1.5

—

0.95

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

263

1517

1.19

1.96

2.0

1.6

32.83

25.56

u/ml

1.44

292

(3034426) Prothrombin time (PT)

276

0.57

1.95

1.1

1.2

27.83

28.39

0.26

276

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

834

0.75

1.94

2.4

2.2

49.58

141.14

ug/min

1.72

190

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

348

1.40

1.91

1.1

—

(3000285) Sodium [Moles/volume] in Blood

360

1.39

1.90

1.3

138.64

138.12

mmol/l

0.39

305

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

189

1569

0.82

1.89

1.2

1.5

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

999

7423

0.92

1.89

2.1

2.5

2.91

2.95

g/l

0.56

816

6616

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

138

1.64

1.85

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

104

918

0.77

1.82

1.5

1.4

37.86

34.23

iu/l

0.41

767

(3016038) Potassium [Moles/volume] in Urine

213

1215

1.20

1.82

1.1

34.14

34.85

mmol/l

0.17

171

1028

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1825

13230

0.94

1.79

2.1

2.5

53.69

47.35

u/l

0.17

1481

11127

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

293

0.61

1.76

1.1

1.3

115.53

113.59

0.17

258

(3015235) Bicarbonate [Moles/volume] in Capillary blood

842

6280

0.91

1.76

2.5

3.1

24.90

24.86

mmol/l

0.12

819

6180

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1832

11838

1.06

1.75

1.9

2.3

401.17

390.12

nmol/l

1.43

1604

10875

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.00

1.75

0.0

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

766

0.76

1.75

4.3

3.2

1.30

1.26

0.07

766

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.03

1.73

1.2

1.0

130.70

191.32

pmol/l

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

749

5612

0.91

1.73

1.1

1.70

5.36

u/ml

0.43

(3006571) Granulocytes/Leukocytes in Synovial fluid

239

1923

0.85

1.72

1.5

67.50

61.84

1.65

152

1199

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

195

0.53

1.71

1.7

1.5

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

176

0.51

1.68

1.3

1.5

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

313

2462

0.87

1.68

1.3

1.4

17.53

13.50

u/ml

—

(40761536) Microorganisms panel - Urine sediment

1670

10776

1.07

1.68

4.9

4.7

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

937

6938

0.92

1.67

1.9

2.4

10.26

10.25

g/l

0.02

737

6049

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

244

0.59

1.63

4.8

7.0

10.79

10.14

0.36

244

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

308

2417

0.87

1.61

1.3

0.81

0.84

nmol/l

0.34

251

1983

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

108

581

1.27

1.61

1.8

2.0

13.86

14.69

nmol/l

0.57

531

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

294

2313

0.87

1.60

5.3

5.9

12.97

12.59

mg/l

0.73

260

2114

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

924

6829

0.92

1.59

2.0

2.6

1.16

1.04

g/l

0.38

718

5750

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

172

1.51

1.58

4.5

3.3

41.04

40.48

umol/l

0.05

139

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

350

0.66

1.57

1.4

1.5

17.55

10.43

0.46

175

(3022764) Mononuclear cells/Leukocytes in Peritoneal fluid

0.00

1.57

0.0

7.3

—

51.85

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

1.56

0.0

1.0

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

181

1475

0.84

1.55

1.1

48.05

367.43

iu/ml

0.92

248

(3020891) Body temperature

1248

8004

1.07

1.53

3.7

4.5

36.91

36.90

°c

0.56

1230

7925

(3036071) Salmonella sp Ab [Titer] in Serum

239

0.60

1.52

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

499

0.73

1.51

1.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.69

1.50

1.0

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

304

0.65

1.48

1.1

17.56

23.69

u/ml

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

16074

111025

0.97

1.46

4.9

5.7

4.29

4.35

mmol/l

10.32

14230

100371

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

612

0.76

1.44

1.0

—

(3020874) Milk IgE Ab [Units/volume] in Serum

218

0.60

1.43

1.0

1.1

0.36

1.00

u/ml

—

(3035611) Eosinophils/Leukocytes in Synovial fluid

105

1.63

1.43

1.7

1.8

1.01

0.80

0.14

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

496

3749

0.90

1.43

2.0

2.3

113.02

108.11

ug/min

0.08

244

2099

(3028626) Oxygen [Partial pressure] in Capillary blood

594

4448

0.91

1.42

2.5

3.1

7.72

7.80

kpa

0.61

577

4351

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

575

4312

0.91

1.41

1.4

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

275

0.65

1.40

1.1

1.2

—

(3001729) Color of Synovial fluid

122

1.57

1.40

1.7

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

268

2097

0.87

1.39

1.3

1.5

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1051

6727

1.07

1.39

1.3

51.35

59.47

au/ml

0.54

435

(3050129) First trimester maternal screen panel - Serum or Plasma

113

0.48

1.39

1.6

1.4

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

1.38

0.0

1.1

—

8.33

—

(3001019) Free T4 and TSH panel - Serum or Plasma

175

1413

0.85

1.38

1.5

1.6

—

(3010838) Calcium [Moles/time] in 24 hour Urine

304

2355

0.88

1.36

1.5

1.8

4.39

4.45

mmol/24h

0.12

242

1992

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

163

0.55

1.36

1.2

1.6

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

102

0.47

1.35

1.0

1.2

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

2.20

1.34

1.0

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

143

814

1.20

1.33

1.2

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

143

814

1.20

1.33

1.2

1.4

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

135

0.51

1.33

1.2

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.69

1.32

1.8

17.31

17.98

umol/l

0.08

(3000093) Morphology [Interpretation] in Blood Narrative

213

1684

0.86

1.30

1.1

—

(3008037) Lactate [Moles/volume] in Venous blood

730

4625

1.08

1.29

3.4

3.6

1.68

1.62

mmol/l

0.95

714

4513

(3000570) Elastase.pancreatic [Mass/mass] in Stool

631

4687

0.92

1.28

1.4

266.47

255.28

ug/g

0.72

360

2901

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

277

0.67

1.28

1.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3413

24125

0.96

1.26

1.3

1.71

1.60

u/ml

0.18

750

5597

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

167

0.57

1.25

1.0

1.1

4.40

19.37

iu/ml

—

(37208534) Antinuclear antibody arbitrary concentration in serum

356

0.71

1.25

1.1

1.0

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

283

0.68

1.24

1.2

1.1

70.27

83.13

1.04

150

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

291

0.68

1.24

1.2

92.54

100.16

0.55

270

(3026726) Creatinine [Moles/volume] in Specimen

140

0.54

1.23

2.9

2.3

161.73

368.81

umol/l

0.91

131

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

140

803

1.19

1.23

2.2

2.0

2.05

2.71

u/field

0.65

529

(3003740) Influenza virus B Ag [Presence] in Specimen

687

0.80

1.22

1.1

—

(3025941) Bacteria identified in Stool by Culture

926

5936

1.07

1.21

1.3

—

(3000330) Specific gravity of Urine by Test strip

1281

8299

1.06

1.21

4.2

4.0

1.02

ratio

4.99

1146

7551

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

384

0.73

1.19

1.2

1.3

—

(40758558) Short blood count panel - Blood

5902

39504

1.03

1.19

5.6

6.8

—

(4015189) Microbial culture of sputum

470

0.76

1.19

2.5

2.3

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

1.71

1.18

1.7

1.5

25.38

23.07

mmol/l

1.28

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

1.18

0.0

2.3

—

3.00

—

(3043410) Blood group antigens tested for on Red Blood Cells

454

0.75

1.18

1.8

2.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

288

0.69

1.18

1.7

10.32

9.91

ug/l

0.21

288

(3034891) Synovial lining cells/cells in Synovial fluid

744

0.81

1.17

1.4

1.5

4.45

3.83

0.16

162

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

174

1.42

1.15

1.0

1.1

—

(3016502) Oxygen saturation in Arterial blood

2750

18176

1.04

1.15

4.8

7.0

95.24

95.16

0.24

2639

17548

(3003329) Lymphocytes/Leukocytes in Synovial fluid

182

1436

0.87

1.13

1.5

21.55

27.20

1.76

112

878

(3000060) B lymphocytes [#/volume] in Blood

203

0.64

1.12

1.9

1.7

0.05

1.36

e9/l

1.80

(3002523) Influenza virus A Ag [Presence] in Specimen

686

0.81

1.11

1.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

113

1.51

1.11

1.0

1.5

1.71

1.07

mmol/l

0.25

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

549

0.78

1.11

1.0

1.1

6.49

12.17

iu/ml

—

106

(4198724) Urine methamphetamine measurement

102

1.54

1.11

1.1

1.3

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

685

0.81

1.10

1.2

1.3

710.44

241.64

ug/l

0.51

372

(3000475) Leukocytes [#/volume] in Synovial fluid

536

3975

0.92

1.09

1.6

18172.94

14921.29

e6/l

0.67

380

2780

(3011288) Drugs identified in Urine by Screen method Nominal

306

1.30

1.09

2.4

1.9

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

151

0.59

1.08

1.2

3.3

—

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

258

0.69

1.08

1.3

1.4

79.99

73.33

0.44

218

(3028433) Virus identified in Specimen by Culture

439

0.76

1.08

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

282

0.70

1.07

1.2

70.75

80.75

0.66

154

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.71

1.06

1.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

4250

29821

0.97

1.04

3.4

3.7

0.82

0.85

ug/l

0.93

3094

22285

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

3997

28066

0.97

1.03

1.6

1.7

1.69

1.59

mg/l

0.83

3114

22420

(3003396) Base excess in Arterial blood by calculation

3047

20235

1.04

1.01

4.7

6.8

1.19

0.98

mmol/l

1.89

2401

16711

(3019977) pH of Arterial blood

3064

20350

1.04

1.01

4.8

6.8

7.42

1.15

1906

11168

(3021901) Oxygen saturation in Capillary blood

534

3944

0.92

1.01

2.5

3.1

88.44

88.86

0.66

517

3847

(3023383) Lactate [Moles/volume] in Pleural fluid

692

0.82

1.01

1.2

1.3

3.95

3.29

mmol/l

0.76

636

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

1.00

0.0

1.2

—

281.95

—

(4146454) Self-monitoring of blood glucose

255

1949

0.89

0.99

2.6

2.7

—

(3001186) Copper [Moles/volume] in Serum or Plasma

215

1.34

0.99

1.2

1.1

16.04

16.53

umol/l

0.31

184

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

211

1278

1.13

0.97

1.4

1.3

470.00

441.71

titre

0.05

111

(3042010) Triglyceride [Moles/volume] in Pleural fluid

331

0.74

0.97

1.1

1.2

0.70

1.38

mmol/l

1.02

216

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

236

0.70

0.97

1.0

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

205

1240

1.13

0.97

1.4

1.3

53.08

66.32

titre

0.27

(3041918) Cholesterol [Moles/volume] in Pleural fluid

408

0.77

0.96

1.1

1.2

1.43

1.47

mmol/l

0.09

259

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

299

0.73

0.96

1.1

1.3

35.85

273.56

u/l

0.88

212

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

461

0.79

0.95

1.5

1.4

0.14

0.17

nmol/l

0.72

309

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

407

3031

0.92

0.95

1.6

1.7

19.61

10.78

iu/l

0.21

142

1014

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

161

1262

0.87

0.95

1.1

78.21

27.99

au/ml

1.43

111

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

227

0.69

0.95

1.0

1.1

—

(3045424) Erythrocytes [Presence] in Urine

1113

7243

1.05

0.95

2.0

2.2

0.00

0.15

estimate

0.58

246

1854

(3022493) Free Hemoglobin [Mass/volume] in Plasma

684

0.83

0.92

1.1

2.7

59.23

69.43

mg/l

0.85

467

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.50

0.92

1.0

—

(40767503) Oxygen content in Capillary blood by calculation

575

3671

1.07

0.91

2.4

2.8

16.19

15.80

2.50

562

3599

(1001926) Buprenorphine [Presence] in Urine by Screen method

358

1.24

0.91

1.8

1.3

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1284

9191

0.95

0.91

1.5

1.7

1.60

1.57

g/l

0.53

1030

7865

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.54

0.90

1.4

1.5

—

(3024263) Appearance of Synovial fluid

123

722

1.17

0.90

1.4

1.5

—

(3027801) Oxygen [Partial pressure] in Arterial blood

3059

20364

1.03

0.89

4.7

6.8

11.73

11.84

kpa

0.48

2926

19502

(3012494) Peanut IgE Ab [Units/volume] in Serum

159

0.65

0.89

1.1

0.14

0.55

u/ml

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

3061

20379

1.03

0.89

4.7

6.8

4.97

5.08

kpa

7.50

2930

19529

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

2.05

0.87

1.0

1.1

—

(3022948) Iron [Moles/volume] in Serum or Plasma

4264

28543

1.03

0.86

2.2

2.7

11.20

11.75

umol/l

5.72

3751

26337

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

300

0.75

0.85

1.0

1.1

95.68

92.54

0.29

213

(3018677) aPTT in Platelet poor plasma by Coagulation assay

3680

24589

1.03

0.85

1.7

2.0

29.39

30.01

8.08

3550

23917

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

3602

25251

0.97

0.85

2.2

2.8

20.32

21.07

2.75

3151

23304

(3017315) Amylase [Enzymatic activity/volume] in Urine

692

0.84

1.2

206.21

352.64

u/l

1.40

636

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

467

0.81

0.83

1.2

1.5

29.35

1504.87

u/l

1.09

168

(3044927) Protein electrophoresis panel - Urine

316

1980

1.09

0.82

1.2

—

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

114

0.60

0.82

2.1

1.7

7.00

17.35

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.81

0.0

1.0

—

2.11

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

102

0.60

0.81

1.0

1.1

12.13

32.95

iu/ml

—

102

(3026051) Granulocytes/Leukocytes in Pleural fluid

487

0.81

0.80

1.3

1.4

17.98

21.11

0.43

408

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

477

1.19

0.80

5.5

6.3

60.05

72.12

2.80

372

(3025018) Bordetella pertussis Ab [Titer] in Serum

479

0.81

0.80

1.2

1.3

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

138

0.64

0.79

1.2

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

349

2202

1.09

0.79

2.0

2.2

28.38

26.24

mg/l

0.27

104

778

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

177

0.70

0.76

1.1

720.00

750.00

titre

—

(3038515) Glucose [Moles/volume] in Venous blood

614

3960

1.06

0.76

3.6

3.8

7.93

7.67

mmol/l

1.20

600

3864

(3020393) Adenovirus Ag [Presence] in Stool

130

1.37

0.75

1.0

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.59

0.75

1.4

1.5

—

(3017569) Oxygen content in Arterial blood

144

1113

0.88

0.74

2.1

2.2

16.29

15.54

2.32

144

1113

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.55

0.74

1.2

1.6

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

172

1.31

0.74

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.84

0.74

1.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.53

0.73

1.2

1.6

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

191

0.72

0.73

1.4

1.2

93.60

76.90

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

653

4720

0.95

0.72

1.1

—

(3020491) Glucose [Moles/volume] in Blood

155

944

1.12

0.72

1.7

2.1

7.40

7.22

mmol/l

0.26

111

638

(44790047) Parainfluenza type 1 nucleic acid detection

242

1814

0.91

0.72

1.4

1.3

—

(44790048) Parainfluenza type 2 nucleic acid detection

242

1814

0.91

0.72

1.4

1.3

—

(44790049) Parainfluenza type 3 nucleic acid detection

242

1814

0.91

0.72

1.4

1.3

—

(44806118) Parainfluenza type 4 nucleic acid detection

242

1814

0.91

0.72

1.4

1.3

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

190

0.72

0.71

1.0

0.49

1.41

u/ml

—

(3016879) Cocaine [Presence] in Urine

422

1.18

0.69

1.8

1.3

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

455

0.83

0.69

1.1

1.05

1.08

ratio

1.38

348

(3006576) Bicarbonate [Moles/volume] in Blood

535

0.84

0.67

3.5

6.6

24.78

24.88

mmol/l

0.09

477

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

898

5881

1.05

0.66

3.1

4.3

25.04

24.89

mmol/l

0.83

763

5350

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

102

798

0.87

0.66

2.0

—

(3035285) Chloride [Moles/volume] in Venous blood

363

2316

1.07

0.66

2.5

2.6

106.17

105.53

mmol/l

1.65

357

2298

(3041354) Potassium [Moles/volume] in Venous blood

363

2316

1.07

0.66

2.5

2.6

4.11

mmol/l

0.01

357

2299

(3017704) Immunofixation for Urine

167

1029

1.11

0.65

1.4

1.5

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.60

0.65

2.4

3.7

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

225

0.76

0.64

1.0

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

101

789

0.88

0.64

1.1

—

(3020650) Glucose [Presence] in Urine

356

1.19

0.64

2.4

1.7

0.00

0.03

estimate

1.34

356

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

1.63

0.63

1.0

1.1

—

(3004451) EKG impression Narrative

149

1135

0.90

0.63

1.3

—

(3000034) Microalbumin [Mass/volume] in Urine

172

1300

0.90

0.63

2.7

3.1

31.26

38.90

mg/l

0.34

125

949

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

224

0.76

0.63

1.0

1.1

20.76

17.89

u/l

0.40

147

(3006462) Nitrate [Presence] in Urine

700

0.87

0.63

4.0

3.9

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

285

0.79

0.63

1.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.61

0.0

1.1

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

2284

15250

1.03

0.60

4.1

6.6

1.45

1.37

mmol/l

3.06

2226

14888

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.52

0.59

1.7

1.6

452.88

418.65

nmol/l

0.08

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.48

0.58

1.2

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

274

0.80

0.58

1.3

1.5

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

190

0.76

0.58

1.2

95.00

70.87

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

357

2291

1.07

0.57

2.5

2.6

1.20

mmol/l

0.00

351

2274

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.56

0.57

1.6

1.5

—

(40762887) Creatinine [Moles/volume] in Blood

125

1.31

0.57

1.4

1.6

—

(3050794) Legionella sp Ab [Presence] in Serum

127

0.70

0.57

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.54

0.57

1.8

1.1

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

0.65

0.56

1.6

1.8

202.25

196.95

ng/l

—

(3003327) Ova and parasites identified in Stool by Light microscopy

477

3444

0.95

0.56

1.5

1.6

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

134

0.71

0.55

1.6

2.8

5.40

15.48

ug/l

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

134

0.71

0.55

1.0

0.04

0.26

u/ml

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

413

0.84

0.54

2.2

2.0

13.98

44.32

u/l

4.04

391

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

157

0.74

0.54

1.6

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

109

834

0.89

0.53

1.2

9.81

9.68

mmol/l

0.10

102

779

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.60

0.53

1.2

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

115

1.31

0.52

1.2

1.0

—

(3012501) Base excess in Blood by calculation

535

3490

1.05

0.51

3.3

4.4

2.40

2.76

mmol/l

2.16

359

2418

(3013290) Carbon dioxide [Partial pressure] in Blood

535

3492

1.05

0.50

3.3

4.4

4.97

5.00

kpa

0.42

516

3405

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

328

0.83

0.50

1.2

1.1

259.12

271.14

pmol/l

0.12

231

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

185

0.78

0.50

1.5

1.7

—

(44806071) Cardiolipin IgM antibody measurement

104

1.32

0.49

1.1

—

(40762814) Titanium [Mass/volume] in Blood

342

0.84

0.49

2.2

2.3

2.81

3.34

ug/l

1.16

129

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

692

0.89

0.49

1.1

1.2

—

(40762365) Oxygen content in Arterial blood by calculation

290

0.83

0.49

1.9

2.8

15.33

14.67

ml/dl

0.97

270

(3000764) Benzodiazepines [Presence] in Urine

444

1.14

0.49

1.8

1.3

—

(3022313) Gas panel - Capillary blood

1090

7695

0.97

0.48

3.0

4.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

106

0.71

0.46

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

114

861

0.91

0.46

1.1

3.50

4.84

eliau/ml

0.37

168

(3032868) Hemoglobin electrophoresis panel in Blood

0.58

0.46

1.8

1.5

—

(44806420) Estimation of glomerular filtration rate

105

796

0.90

0.46

2.6

2.7

—

(3002619) Bacteria identified in Specimen by Culture

370

1.15

0.45

1.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

188

1386

0.93

0.45

1.3

1.5

—

(37021550) Renin [Units/volume] in Plasma --upright

294

0.84

0.45

1.4

1.2

41.41

76.87

mu/l

1.65

206

(3007853) Bacteria identified in Skin by Aerobe culture

2511

16874

1.02

0.43

1.7

1.9

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

208

1524

0.93

0.43

1.3

1.4

208011.10

171172.86

e6/l

0.21

127

1026

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1448

9668

1.03

0.43

2.5

3.8

24.36

24.15

mmol/l

1.63

1413

9530

(3025296) Carrot IgE Ab [Units/volume] in Serum

0.00

0.42

0.0

1.0

—

0.02

—

(3009992) Blasts/cells in Bone marrow

0.00

0.42

0.0

1.5

—

22.18

—

(3027008) Opiates [Presence] in Urine

450

1.13

0.42

1.8

1.3

—

(3028300) Cannabinoids [Presence] in Urine

450

1.13

0.42

1.8

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

315

2275

0.95

0.42

1.1

3.07

3.67

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

418

1.13

0.42

1.7

1.6

0.38

0.39

ug/l

0.10

268

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.42

0.0

1.0

—

0.04

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

0.42

0.0

1.0

—

1.16

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.42

0.0

1.1

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.42

0.0

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

682

0.90

0.41

1.1

1.2

—

(3024928) Oxygen saturation in Venous blood

624

4115

1.04

0.41

1.8

2.6

57.59

59.17

0.95

583

3944

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

16136

110844

0.99

0.40

21.0

21.9

69.15

70.01

ml/min/173m2

7.21

15149

104061

(3046861) Legionella sp Ag [Presence] in Urine

102

1.28

0.40

1.0

1.1

—

(4211845) Urine protein measurement

100

751

0.91

0.39

3.9

3.8

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.37

0.39

1.1

1.2

—

(3020618) Glucose [Moles/volume] in Synovial fluid

1.35

0.38

1.0

4.66

5.40

mmol/l

—

(3000012) Reticulocyte production index

408

2918

0.96

0.38

1.8

2.3

0.85

0.90

1.18

272

2061

(3027315) Oxygen [Partial pressure] in Blood

534

3517

1.04

0.38

3.3

4.5

8.19

8.34

kpa

1.12

514

3430

(3016244) Insulin [Units/volume] in Serum or Plasma

303

0.86

0.38

1.6

2.1

20.69

18.51

mu/l

0.17

276

(43055514) Macroprolactin [Presence] in Serum or Plasma

0.70

0.38

1.0

1.4

—

(3020961) Endomysium IgA Ab [Titer] in Serum

607

4304

0.96

0.38

1.1

203.21

182.41

titre

0.08

(3052851) Hemolysis interference index of Serum or Plasma

639

4523

0.97

0.37

3.4

3.7

1.73

1.85

index

0.22

316

2307

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

316

0.87

0.36

1.1

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1459

9775

1.02

0.35

2.8

3.8

1.88

2.03

mmol/l

0.79

1023

7264

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

372

1.12

0.35

1.3

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

686

4550

1.03

0.35

5.2

4.8

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

145

0.80

0.34

1.5

2.26

41.53

pmol/l

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

189

0.83

0.33

2.0

2.4

0.61

0.67

ug/l

0.32

189

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

374

1.12

0.33

1.3

27.30

34.82

0.92

247

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.32

0.33

1.1

—

(3049717) Cytology report of Urine Cyto stain

1118

7478

1.02

0.32

2.7

2.9

—

(3014891) Appearance of Pleural fluid

320

0.88

0.32

1.4

1.6

—

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

0.75

0.32

1.3

0.40

0.75

ml/s/173m2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

727

0.92

0.31

1.9

38.14

39.68

g/l

1.85

727

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.71

0.31

7.9

8.9

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

326

0.88

0.31

1.3

1.18

mmol/l

0.03

326

(3028679) Herpes simplex virus Ab [Presence] in Serum

415

1.11

0.31

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.77

0.31

1.5

1.2

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

350

1.11

0.31

2.5

7.45

7.68

mmol/l

0.23

229

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

304

1992

1.05

0.30

1.2

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

285

1865

1.05

0.30

1.2

1.4

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

216

0.86

0.30

1.1

1.3

15.04

15.10

mm/h

0.01

216

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.32

0.30

1.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

113

1.21

0.29

1.9

1.8

—

(3030313) Adrenal Ab [Titer] in Serum

1.34

0.29

1.0

—

12.29

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

285

1868

1.04

0.29

1.2

1.4

—

(3037121) Protein [Mass/volume] in Urine

781

5480

0.97

0.28

2.4

3.0

354.28

613.71

mg/l

1.89

257

2407

(3051101) Glucose [Moles/volume] in Cord blood

330

0.89

0.28

4.4

6.1

9.36

8.54

mmol/l

1.05

330

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2531

17545

0.99

0.28

5.0

5.6

34.64

33.75

3.40

1550

11008

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

352

2499

0.96

0.27

1.7

2.2

32.79

32.40

1.02

347

2484

(3023511) Choriogonadotropin [Units/volume] in Urine

0.78

0.27

1.7

1.3

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

985

6885

0.98

0.27

2.7

3.4

4.32

pmol/l

0.00

840

6002

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

103

0.80

0.26

1.0

1.2

10.84

10.01

mmol/l

0.47

(3045683) HLA typing for celiac disease panel - Blood or Tissue

374

1.10

0.26

1.1

1.0

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.24

0.26

1.0

1.2

—

(3009015) Lactate [Moles/volume] in Synovial fluid

191

0.86

0.26

1.1

1.3

6.51

7.08

mmol/l

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

177

1151

1.05

0.26

1.1

1.2

—

(3032773) Endomysium IgG Ab [Titer] in Serum

127

923

0.94

0.26

1.0

1.1

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

447

1.09

0.25

1.3

1.4

72.08

60.35

2.28

385

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

244

1.12

0.25

1.1

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

133

964

0.94

0.25

1.6

1.9

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1150

7729

1.02

0.25

1.7

1.9

2.53

2.14

ug/l

0.35

906

6801

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.72

0.24

1.2

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.71

0.24

1.5

1.6

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.70

0.24

1.7

2.8

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.29

0.24

1.6

1.3

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

297

0.90

0.23

1.2

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

138

0.84

0.23

1.0

—

(3010421) pH of Blood

784

5253

1.02

0.23

2.9

3.9

7.41

0.47

765

5176

(3021387) Prolactin [Units/volume] in Serum or Plasma

183

1311

0.95

0.23

2.2

1.9

311.37

298.67

mu/l

0.20

166

1208

(3017461) Flecainide [Moles/volume] in Serum or Plasma

101

0.81

0.23

1.4

1.6

0.51

0.88

umol/l

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

292

1.10

0.23

1.4

1.2

1.25

35.28

mg/l

0.79

215

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.80

0.23

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

404

1.08

0.23

1.0

1.1

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.0

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

282

1864

1.04

0.22

1.2

1.4

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

0.22

0.0

1.1

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.22

0.0

1.0

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.22

0.0

1.0

—

2.07

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

0.22

0.0

1.1

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.22

0.0

1.0

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

0.22

0.0

1.0

—

241.88

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

0.21

0.0

1.3

—

(3038413) Eosinophils/Leukocytes in Peritoneal dialysis fluid by Manual count

0.00

0.21

0.0

6.4

—

8.00

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

0.21

0.0

1.1

—

2.57

—

(3036670) Protein [Mass/volume] in Synovial fluid

571

0.93

0.21

1.2

1.3

40.86

40.48

g/l

0.09

275

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

105

760

0.95

0.20

1.0

1.1

5.08

10.00

nmol/l

0.74

160

(3025577) Chromium [Mass/volume] in Blood

174

1143

1.04

0.19

2.0

2.2

1.84

2.32

ug/l

1.79

146

944

(4133840) Spirometry

200

0.89

0.19

1.5

1.2

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

512

0.94

0.19

1.6

1.7

5.85

6.18

nmol/l

0.04

442

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

184

1.12

0.19

1.2

1.1

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

3970

26978

1.01

0.19

2.1

2.7

2.21

2.25

g/l

4.55

3467

24744

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

476

0.93

0.18

1.1

—

(3015956) Eosinophils/Leukocytes in Blood by Manual count

198

1.11

0.18

2.8

1.98

2.10

0.11

192

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.18

0.17

1.1

6.20

6.25

mmol/l

0.16

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

0.76

0.17

1.0

1.1

—

35.67

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

144

1026

0.96

0.17

1.1

1.2

98.26

102.69

pmol/l

0.50

144

1026

(3027944) Amphetamines [Presence] in Urine

431

1.06

0.16

1.9

1.3

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

160

1.11

0.16

3.3

5.7

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

140

0.88

0.16

1.1

1.2

1.69

1.67

umol/24h

0.05

140

(40765089) Chromosome analysis panel - Blood by G-banded

0.76

0.16

1.2

1.0

—

(1616796) Gas panel - Central venous blood

567

3945

0.98

0.14

2.9

4.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.83

0.14

1.3

1.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.84

0.14

1.0

1.1

0.07

0.03

u/ml

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.79

0.14

1.0

1.3

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

228

1.08

0.13

1.1

1.3

91.10

103.12

ug/l

0.24

139

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

616

0.96

0.13

1.0

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

16650

113787

1.01

0.13

5.8

6.7

2.40

2.46

mmol/l

12.68

14778

102529

(3019174) dRVVT (LA screen)

1.16

0.13

1.0

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

189

1.09

0.13

1.2

1.0

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

180

0.91

0.12

1.3

1.7

41.17

49.36

umol/l

0.94

180

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

110

1.12

0.12

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

110

1.12

0.12

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

110

1.12

0.12

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

118

780

1.04

0.12

1.8

2.1

15.34

27.95

umol/l

1.07

(44786800) Granulocytes/Leukocytes in Body fluid

271

0.93

0.12

1.3

1.4

17.33

21.30

0.33

212

(3026389) Candida sp identified in Specimen by Organism specific culture

267

1864

0.98

0.11

1.4

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2162

14705

1.01

0.10

1.8

2.1

0.20

g/l

0.33

1915

13590

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

533

1.04

0.10

1.9

369.44

336.35

mu/l

0.34

416

(3026470) Cobalt [Mass/volume] in Blood

178

1189

1.02

0.10

2.0

2.1

3.18

3.99

ug/l

1.13

166

1098

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

238

1.06

0.10

1.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.12

0.10

3.1

5.0

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

292

1964

1.02

0.09

1.2

1.4

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.07

0.09

1.0

1.1

1.40

2.72

—

(3033086) Enterovirus Ab [Titer] in Serum

1.04

0.09

1.0

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.80

0.08

1.0

1.2

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.80

0.08

1.4

1.3

23.00

66.67

umol/24h

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

0.78

0.08

5.2

6.0

0.86

0.89

mg/l

—

(36660697) Celiac disease serology panel - Serum

1289

8766

1.01

0.08

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

159

1066

1.02

0.07

3.1

2.9

30.84

32.68

mg/l

0.24

122

800

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.06

0.07

1.1

294.44

286.35

nmol/l

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

355

0.96

0.06

1.1

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1660

11413

1.00

0.06

2.9

4.0

5.17

5.15

kpa

0.53

1505

10876

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1395

9593

0.99

0.06

6.0

9.0

15.85

15.77

0.59

1342

9282

(3013512) EKG study

7704

52798

1.00

0.05

4.4

0.86

0.73

0.94

147

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

288

1951

1.01

0.05

1.2

1.4

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

129

1.06

0.05

1.2

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

353

1.03

0.04

1.2

1.1

1713.06

1655.39

miu/ml

0.13

353

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

523

1.02

0.04

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

393

0.98

0.04

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

239

1651

0.99

0.04

3.3

3.6

11.69

12.40

index

0.55

109

866

(3033923) Metanephrine [Moles/time] in 24 hour Urine

310

0.97

0.04

1.3

1.1

0.60

0.65

umol/24h

0.34

139

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

230

1586

0.99

0.03

2.9

2.8

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

398

0.98

0.03

1.1

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

539

1.02

0.03

1.3

10.39

14.08

umol/l

0.48

376

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

187

1269

1.01

0.02

1.2

1.17

1.52

nmol/l

7.36

169

1148

(3006442) Creatine [Moles/volume] in Serum or Plasma

107

724

1.01

0.02

2.1

1.7

90.95

97.66

umol/l

0.81

107

724

(3024869) Neuronal Ab [Presence] in Serum

301

0.98

0.02

1.0

1.1

—

(4212803) Bone marrow aspirate examination

163

0.97

0.02

1.1

1.0

—

(3037756) Immunofixation for Serum or Plasma

620

4231

1.00

0.02

1.4

1.6

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

266

0.98

0.02

1.1

1.2

—

(3009343) pH of Capillary blood

1623

11117

1.00

0.01

2.9

4.0

7.42

0.14

1336

9358

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.05

0.00

1.1

109.33

105.85

titre

0.07

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.05

0.00

1.2

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

434

1.01

0.00

1.1

1.2

10.73

14.06

pmol/l

0.37

164

(3044009) aPTT.lupus sensitive (LA screen)

1.04

0.00

1.0

1.2

—

(3025549) Creatine [Moles/time] in 24 hour Urine

133

1.03

0.00

1.4

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

347

1.01

0.00

1.1

1.50

13.45

u/ml

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

620

4244

1.00

0.00

1.2

1.3

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

1.04

0.00

1.3

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

107

1.02

0.00

1.1

8.94

10.93

u/l

0.35

107

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

180

0.99

0.00

1.0

1.3

3104.07

163.39

ng/l

0.51

121

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

181

0.98

0.00

2.7

1.3

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

0.95

0.00

1.5

1.3

1.17

1.02

u/field

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.91

-0.00

1.0

1.1

1.33

1.00

u/field

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

23.67

—

(3039621) Maximum lysis.intrinsic coagulation system activated.heparin insensitive [Length fraction] in Blood by Rotational TEG

0.00

-0.00

0.0

2.5

—

4.67

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.98

-0.00

1.0

77.00

513.00

u/l

—

(3011324) Intrinsic factor Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

1.00

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

-0.00

0.0

1.6

—

(3019529) Immunofixation for Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

5.4

—

0.29

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3045191) Normetanephrine [Moles/volume] in Urine

0.00

-0.00

0.0

1.2

—

2.52

—

(3042628) Porphyrins [Moles/volume] in Urine

0.00

-0.00

0.0

1.2

—

(36304079) Mucus [Presence] in Urine sediment

0.00

-0.00

0.0

1.2

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: G6_NEURODEGENERATIVE – Unspecific neurodegenerative disorder

GWS hits: 50

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Unspecific neurodegenerative disorder

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Unspecific neurodegenerative disorder (G6_NEURODEGENERATIVE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints